{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.14.10-dev",
    "document_metadata": {
      "name": "Dendritic Cell Signaling-2.0-Hs",
      "authors": "Causal Biological Networks Database",
      "licenses": "\t        Please cite:\t\t        - www.causalbionet.com\t        - https://bionet.sbvimprover.com\t\t        as well as any relevant publications.\t\t        The sbv IMPROVER project, the website and the Symposia are part of a collaborative project\t        designed to enable scientists to learn about and contribute to the development of a new crowd\t        sourcing method for verification of scientific data and results. The current challenges, website\t        and biological network models were developed and are maintained as part of a collaboration among\t        Selventa, OrangeBus and ADS. The project is led and funded by Philip Morris International. For more\t        information on the focus of Philip Morris International’s research, please visit www.pmi.com.\t        ",
      "version": "2.0",
      "contact": "CausalBiologicalNetworks.RD@pmi.com",
      "description": "The Dendritic Cell Signaling network depicts the causal mechanisms in key cytokine pathways leading to the activation of dendritic cells and their migration to both the lung tissue and lymph nodes. Chemokines and surface receptors expressed by dendritic cells that serve to promote T-cell migration and subsequent differentiation in the lung during COPD are included in the network. Reviewed during Jamboree2014"
    },
    "namespace_url": {},
    "namespace_pattern": {
      "chebi": ".*",
      "mgi": ".*",
      "fplx": ".*",
      "go": ".*",
      "hgnc": ".*"
    },
    "annotation_url": {},
    "annotation_pattern": {
      "cl": ".*"
    },
    "annotation_list": {}
  },
  "nodes": [
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "leukotriene B4",
        "identifier": "15647"
      },
      "id": "e58243d52d8ec8fffcf448f53194016f",
      "bel": "a(chebi:15647 ! \"leukotriene B4\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "hyaluronic acid",
        "identifier": "16336"
      },
      "id": "c67353f967bb4cd9c5d9c2fbdc50ba6c",
      "bel": "a(chebi:16336 ! \"hyaluronic acid\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "lipopolysaccharide",
        "identifier": "16412"
      },
      "id": "4c0f33b1ce0c790c28b9398a8901620a",
      "bel": "a(chebi:16412 ! lipopolysaccharide)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "reactive oxygen species",
        "identifier": "26523"
      },
      "id": "daea6f4eb51dba973002f435187fa6d2",
      "bel": "a(chebi:26523 ! \"reactive oxygen species\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "myeloid dendritic cell activation",
        "identifier": "0001773"
      },
      "id": "78d046cef957285cd4d82fe66ff07406",
      "bel": "bp(go:0001773 ! \"myeloid dendritic cell activation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "natural killer cell proliferation",
        "identifier": "0001787"
      },
      "id": "11c4ad81682368c8b38c70caee4d3012",
      "bel": "bp(go:0001787 ! \"natural killer cell proliferation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "dendritic cell antigen processing and presentation",
        "identifier": "0002468"
      },
      "id": "8df1a0e1752ef4231c52ddf579d7665f",
      "bel": "bp(go:0002468 ! \"dendritic cell antigen processing and presentation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "actin filament polymerization",
        "identifier": "0030041"
      },
      "id": "ee6c57ef6ec7acd5d58a59f1884e8244",
      "bel": "bp(go:0030041 ! \"actin filament polymerization\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "natural killer cell activation",
        "identifier": "0030101"
      },
      "id": "408724f5e49a39347cf49fa6394ffc48",
      "bel": "bp(go:0030101 ! \"natural killer cell activation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "T cell activation",
        "identifier": "0042110"
      },
      "id": "3c6264cd3c943077246031658bae1ac0",
      "bel": "bp(go:0042110 ! \"T cell activation\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "IKK_complex",
        "identifier": "IKK_complex"
      },
      "id": "6e18bd5d8e6b69d668802c71c895ce85",
      "bel": "complex(fplx:\"IKK_complex\" ! \"IKK_complex\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "AP1",
        "identifier": "AP1"
      },
      "id": "0083d297c265cb2ade870cd66cc5abb0",
      "bel": "complex(fplx:AP1 ! AP1)"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "C1q",
        "identifier": "C1q"
      },
      "id": "1768297f6331617655b60aeb7414559d",
      "bel": "complex(fplx:C1q ! C1q)"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "NFkappaB",
        "identifier": "NFkappaB"
      },
      "id": "a7edecc930194d4eff939b226f91107f",
      "bel": "complex(fplx:NFkappaB ! NFkappaB)"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "PI3K",
        "identifier": "PI3K"
      },
      "id": "2de818cb7bd5f3eacdbb22c78861bdd8",
      "bel": "complex(fplx:PI3K ! PI3K)"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "IL12A",
            "identifier": "5969"
          },
          "id": "6051b00924e029743acb4fb37328917c",
          "bel": "p(hgnc:5969 ! IL12A)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "IL12B",
            "identifier": "5970"
          },
          "id": "ccb0be98e961d2a673a4b5f9bc55b587",
          "bel": "p(hgnc:5970 ! IL12B)"
        }
      ],
      "id": "48741cb4e3d769f71a801b7ff04ab4e2",
      "bel": "complex(p(hgnc:5969 ! IL12A), p(hgnc:5970 ! IL12B))"
    },
    {
      "function": "miRNA",
      "concept": {
        "namespace": "hgnc",
        "name": "MIR9-1",
        "identifier": "31641"
      },
      "id": "049e2a349b63da56847fed1442cd59f4",
      "bel": "m(hgnc:31641 ! \"MIR9-1\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "Chemokine_receptor",
        "identifier": "Chemokine_receptor"
      },
      "id": "4515b7a6175e28b864bd074c1abf4330",
      "bel": "p(fplx:\"Chemokine_receptor\" ! \"Chemokine_receptor\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PI3K_p110",
        "identifier": "PI3K_p110"
      },
      "id": "8b79e969188c2874eba3fa100a633e65",
      "bel": "p(fplx:\"PI3K_p110\" ! \"PI3K_p110\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "ERK",
        "identifier": "ERK"
      },
      "id": "44a9148a4c46d6790c5018593934ee6c",
      "bel": "p(fplx:ERK ! ERK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "JNK",
        "identifier": "JNK"
      },
      "id": "2f6658f9c547f93c3f37c98276d1a287",
      "bel": "p(fplx:JNK ! JNK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "MEK",
        "identifier": "MEK"
      },
      "id": "8812524d09d27ead405ac6981c8205a2",
      "bel": "p(fplx:MEK ! MEK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "RHO",
        "identifier": "RHO"
      },
      "id": "3b3b73ef9cd6f44d5f0a6255069b551a",
      "bel": "p(fplx:RHO ! RHO)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "TGFB",
        "identifier": "TGFB"
      },
      "id": "2ea3a352aefaf597fbda8a8606b415ff",
      "bel": "p(fplx:TGFB ! TGFB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "p38",
        "identifier": "p38"
      },
      "id": "16819634e2bac5ec6d922818bf87ef22",
      "bel": "p(fplx:p38 ! p38)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL14",
        "identifier": "10612"
      },
      "id": "85ab7df031b5a3f6bafaae3a278bec01",
      "bel": "p(hgnc:10612 ! CCL14)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL16",
        "identifier": "10614"
      },
      "id": "81f4e96a33a5d041c936f5c69d190a70",
      "bel": "p(hgnc:10614 ! CCL16)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL19",
        "identifier": "10617"
      },
      "id": "027e3d162770ecaf6cd673ad33a3d69b",
      "bel": "p(hgnc:10617 ! CCL19)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL2",
        "identifier": "10618"
      },
      "id": "dd9ab9eb67b7e4e63dbde1ec97117509",
      "bel": "p(hgnc:10618 ! CCL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL20",
        "identifier": "10619"
      },
      "id": "7a80094bfa73a2d48c2522a4cc4936c1",
      "bel": "p(hgnc:10619 ! CCL20)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL21",
        "identifier": "10620"
      },
      "id": "248c7fa1b4342121ed6d674fbddd4813",
      "bel": "p(hgnc:10620 ! CCL21)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL3",
        "identifier": "10627"
      },
      "id": "b679d54febd9f7900d3fe8a8993b5826",
      "bel": "p(hgnc:10627 ! CCL3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL4",
        "identifier": "10630"
      },
      "id": "21c90616454adb8be8a9291e0aece957",
      "bel": "p(hgnc:10630 ! CCL4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL5",
        "identifier": "10632"
      },
      "id": "9ffa071bf151e5d66fe67d459ae75286",
      "bel": "p(hgnc:10632 ! CCL5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL7",
        "identifier": "10634"
      },
      "id": "ed1395d85516b505fab86d98a8722674",
      "bel": "p(hgnc:10634 ! CCL7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL8",
        "identifier": "10635"
      },
      "id": "5d7594e1246ad7c8a133e9176cbfda48",
      "bel": "p(hgnc:10635 ! CCL8)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL10",
        "identifier": "10637"
      },
      "id": "332bc9461b0555e1895dd1d495ceb1b0",
      "bel": "p(hgnc:10637 ! CXCL10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL11",
        "identifier": "10638"
      },
      "id": "037221f42dac94f1665006e422e8a5a4",
      "bel": "p(hgnc:10638 ! CXCL11)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CX3CL1",
        "identifier": "10647"
      },
      "id": "c1eb12de9280eafe7408108ab1f8f369",
      "bel": "p(hgnc:10647 ! CX3CL1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SPP1",
        "identifier": "11255"
      },
      "id": "d91ea27016fc48f70846d599abc4da13",
      "bel": "p(hgnc:11255 ! SPP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "STAT3",
        "identifier": "11364"
      },
      "id": "16cbb4ba8a8e57b2fe2119d9545dd71a",
      "bel": "p(hgnc:11364 ! STAT3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TBK1",
        "identifier": "11584"
      },
      "id": "ef479aed4e29db6f1a47afe31d118d8b",
      "bel": "p(hgnc:11584 ! TBK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TGFBR1",
        "identifier": "11772"
      },
      "id": "6cbcf911f2657f94fd0d724a01f99d50",
      "bel": "p(hgnc:11772 ! TGFBR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR2",
        "identifier": "11848"
      },
      "id": "232d82289f579d65f6295b7015f8cea0",
      "bel": "p(hgnc:11848 ! TLR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR3",
        "identifier": "11849"
      },
      "id": "d52e3aab8cf8bfd56cb57d86d4186ab4",
      "bel": "p(hgnc:11849 ! TLR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR4",
        "identifier": "11850"
      },
      "id": "3757d476c6399f77b225fb8b1522441c",
      "bel": "p(hgnc:11850 ! TLR4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD40",
        "identifier": "11919"
      },
      "id": "ecbfb7106ee2027ee7166d4b00e9bd7a",
      "bel": "p(hgnc:11919 ! CD40)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD40LG",
        "identifier": "11935"
      },
      "id": "0210088919155804f6f7e88ca8284878",
      "bel": "p(hgnc:11935 ! CD40LG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TRAF6",
        "identifier": "12036"
      },
      "id": "37a2e1215f3675b4f3bbc3d43024d047",
      "bel": "p(hgnc:12036 ! TRAF6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TRB",
        "identifier": "12155"
      },
      "id": "53eb17c2956741e1c90016a2f11b8a86",
      "bel": "p(hgnc:12155 ! TRB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "C1QA",
        "identifier": "1241"
      },
      "id": "514d2c53e4f02b4a95ac50310efdce6b",
      "bel": "p(hgnc:1241 ! C1QA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "C1QB",
        "identifier": "1242"
      },
      "id": "85c9159355ca04ad0bec230da195259d",
      "bel": "p(hgnc:1242 ! C1QB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "C1QC",
        "identifier": "1245"
      },
      "id": "48c9c9ccdea7fb58e3cfb7db0c2a176e",
      "bel": "p(hgnc:1245 ! C1QC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VEGFA",
        "identifier": "12680"
      },
      "id": "710d068636280068962cf864d9ed7526",
      "bel": "p(hgnc:12680 ! VEGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "C3",
        "identifier": "1318"
      },
      "id": "6d8e8d2f843fb3570958cc04bf44d0d3",
      "bel": "p(hgnc:1318 ! C3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "C3AR1",
        "identifier": "1319"
      },
      "id": "9c681d92ef02ced382d19966013c2921",
      "bel": "p(hgnc:1319 ! C3AR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "C5",
        "identifier": "1331"
      },
      "id": "66b94f0d12d3ffbd7eed01346b8b067d",
      "bel": "p(hgnc:1331 ! C5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "C5AR1",
        "identifier": "1338"
      },
      "id": "25fdabf27c3439d25347bf26bb14bddf",
      "bel": "p(hgnc:1338 ! C5AR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKE",
        "identifier": "14552"
      },
      "id": "c0329353de09247a519ba5d21da15273",
      "bel": "p(hgnc:14552 ! IKBKE)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR9",
        "identifier": "15633"
      },
      "id": "7881560a3f60af011403850900dbdeb8",
      "bel": "p(hgnc:15633 ! TLR9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCR1",
        "identifier": "1602"
      },
      "id": "d28da232ffd3d3c52f906f12bf1f4e15",
      "bel": "p(hgnc:1602 ! CCR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCR2",
        "identifier": "1603"
      },
      "id": "d86e49c0eaea8e8cb526d66774496a73",
      "bel": "p(hgnc:1603 ! CCR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCR3",
        "identifier": "1604"
      },
      "id": "d7e8723890bbe6bb5c4ddcc979600822",
      "bel": "p(hgnc:1604 ! CCR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCR5",
        "identifier": "1606"
      },
      "id": "3bd403e2cde82f89f351e09ec8c92573",
      "bel": "p(hgnc:1606 ! CCR5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCR6",
        "identifier": "1607"
      },
      "id": "25d46bd93f0b100101cb807cb70fa0cc",
      "bel": "p(hgnc:1607 ! CCR6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCR7",
        "identifier": "1608"
      },
      "id": "84294a6004e6c21a08cf86eb1bd35efb",
      "bel": "p(hgnc:1608 ! CCR7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD28",
        "identifier": "1653"
      },
      "id": "0a86bc66ae91b0020ed3b4fc1248e129",
      "bel": "p(hgnc:1653 ! CD28)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL16",
        "identifier": "16642"
      },
      "id": "b4cd3dfdf3c1995bb870bf2e86ab51da",
      "bel": "p(hgnc:16642 ! CXCL16)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCR6",
        "identifier": "16647"
      },
      "id": "30165c4ed1f5c9ead1ff8b36a512a3a9",
      "bel": "p(hgnc:16647 ! CXCR6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD80",
        "identifier": "1700"
      },
      "id": "eee16705db6f729589e61eee54d80859",
      "bel": "p(hgnc:1700 ! CD80)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD83",
        "identifier": "1703"
      },
      "id": "40723cf0bab5e6c6bb44b83f2e5507fe",
      "bel": "p(hgnc:1703 ! CD83)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD86",
        "identifier": "1705"
      },
      "id": "c7369eb3beb27f06bba5f5ccc27d45c4",
      "bel": "p(hgnc:1705 ! CD86)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRAK4",
        "identifier": "17967"
      },
      "id": "ec40f08ca8951d274431a47926fb8ce0",
      "bel": "p(hgnc:17967 ! IRAK4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TICAM1",
        "identifier": "18348"
      },
      "id": "6b92d9a31d53b28f6727549bff73dd82",
      "bel": "p(hgnc:18348 ! TICAM1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IFNL1",
        "identifier": "18363"
      },
      "id": "facb3db1fc43f75577418bca0dac3e7e",
      "bel": "p(hgnc:18363 ! IFNL1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CFL1",
        "identifier": "1874"
      },
      "id": "db1fae06f63faa132958d25e4cb41099",
      "bel": "p(hgnc:1874 ! CFL1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SOCS3",
        "identifier": "19391"
      },
      "id": "735fdfba2945662cdbf7680ba8d40a73",
      "bel": "p(hgnc:19391 ! SOCS3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CHUK",
        "identifier": "1974"
      },
      "id": "db3393599a0e7a8a656b31553362680e",
      "bel": "p(hgnc:1974 ! CHUK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CX3CR1",
        "identifier": "2558"
      },
      "id": "0fec6d343aeb663d7da264a28e5f0f29",
      "bel": "p(hgnc:2558 ! CX3CR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TSLP",
        "identifier": "30743"
      },
      "id": "a60b71cf5cbd26a58d4bea2d666d140c",
      "bel": "p(hgnc:30743 ! TSLP)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOS",
        "identifier": "3796"
      },
      "id": "51b3dd9db2c79b87b3e8d0248fe2ddd3",
      "bel": "p(hgnc:3796 ! FOS)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AKT1",
        "identifier": "391"
      },
      "id": "3adaa3ad564b6e0ae1b7c41879193857",
      "bel": "p(hgnc:391 ! AKT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCR3",
        "identifier": "4540"
      },
      "id": "77011f5500949aef21d289c3f86a20b8",
      "bel": "p(hgnc:4540 ! CXCR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL2",
        "identifier": "4603"
      },
      "id": "86f9b14beaa9ac5107f78995c359f8f1",
      "bel": "p(hgnc:4603 ! CXCL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HMGB1",
        "identifier": "4983"
      },
      "id": "398b09638fb3ccb8b0fa665e9b95658b",
      "bel": "p(hgnc:4983 ! HMGB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IFNA4",
        "identifier": "5425"
      },
      "id": "7180e102c3b021bb48186d6bd9d74cdd",
      "bel": "p(hgnc:5425 ! IFNA4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IFNB1",
        "identifier": "5434"
      },
      "id": "73e74c29ec966f5c26691f7c34bd80c4",
      "bel": "p(hgnc:5434 ! IFNB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "id": "7a4749b50b3cb8b62deb0877730ffbce",
      "bel": "p(hgnc:5960 ! IKBKB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 177
        }
      ],
      "id": "371fe0ff8b204c13fba9d531feea3f69",
      "bel": "p(hgnc:5960 ! IKBKB, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 177))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 181
        }
      ],
      "id": "b62e75d57cea6c2701117373069dcb4c",
      "bel": "p(hgnc:5960 ! IKBKB, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 181))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKG",
        "identifier": "5961"
      },
      "id": "b57d2b2b7d37a0917ab8f7e2986c2a1c",
      "bel": "p(hgnc:5961 ! IKBKG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL10",
        "identifier": "5962"
      },
      "id": "d8c40c6a1f13eedcc2609d52f062607c",
      "bel": "p(hgnc:5962 ! IL10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL12A",
        "identifier": "5969"
      },
      "id": "6051b00924e029743acb4fb37328917c",
      "bel": "p(hgnc:5969 ! IL12A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL12B",
        "identifier": "5970"
      },
      "id": "ccb0be98e961d2a673a4b5f9bc55b587",
      "bel": "p(hgnc:5970 ! IL12B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL15",
        "identifier": "5977"
      },
      "id": "716e2b97037ca2f5fb8aeeaaf64e78dc",
      "bel": "p(hgnc:5977 ! IL15)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL15RA",
        "identifier": "5978"
      },
      "id": "a4f612c28eca5d947b5db7a54138900f",
      "bel": "p(hgnc:5978 ! IL15RA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL2",
        "identifier": "6001"
      },
      "id": "03965642c6a230d83212d22d0e2e4533",
      "bel": "p(hgnc:6001 ! IL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL2RB",
        "identifier": "6009"
      },
      "id": "d51c0b670432c790eeef590bdeebd2d6",
      "bel": "p(hgnc:6009 ! IL2RB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL4",
        "identifier": "6014"
      },
      "id": "b2dc2b588b6dc1976273a46353ae2435",
      "bel": "p(hgnc:6014 ! IL4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL6",
        "identifier": "6018"
      },
      "id": "aa9c1c139b580c6add7164eef64ebb80",
      "bel": "p(hgnc:6018 ! IL6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL8",
        "identifier": "6025"
      },
      "id": "ff6d8ebf56ab67532ff6ab8e1ad8745c",
      "bel": "p(hgnc:6025 ! CXCL8)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRAK1",
        "identifier": "6112"
      },
      "id": "3ca6a22c2e3d76a60409eb45e5c12106",
      "bel": "p(hgnc:6112 ! IRAK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRF3",
        "identifier": "6118"
      },
      "id": "9aec7805943771168c74ad61e15f4c09",
      "bel": "p(hgnc:6118 ! IRF3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRF7",
        "identifier": "6122"
      },
      "id": "88d701e8400f51cb9a7ab89b2e7b1e90",
      "bel": "p(hgnc:6122 ! IRF7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RHOA",
        "identifier": "667"
      },
      "id": "7d595d03c52521703630f503febe384c",
      "bel": "p(hgnc:667 ! RHOA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RHOB",
        "identifier": "668"
      },
      "id": "a71b04401b0bcfc84ec1d9f3559d5191",
      "bel": "p(hgnc:668 ! RHOB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RHOC",
        "identifier": "669"
      },
      "id": "3299fd656ec751c20f254892b31a2f8e",
      "bel": "p(hgnc:669 ! RHOC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP2K4",
        "identifier": "6844"
      },
      "id": "301473bba7664a8e1cb76865fff65a50",
      "bel": "p(hgnc:6844 ! MAP2K4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K7",
        "identifier": "6859"
      },
      "id": "e78712bc62bb428b8e61d97e9c0da6a7",
      "bel": "p(hgnc:6859 ! MAP3K7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK1",
        "identifier": "6871"
      },
      "id": "e0c0225b558aed46aa00177aa93224b5",
      "bel": "p(hgnc:6871 ! MAPK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK11",
        "identifier": "6873"
      },
      "id": "fcd46ddadc9a22ab148c5fc55a94e879",
      "bel": "p(hgnc:6873 ! MAPK11)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK14",
        "identifier": "6876"
      },
      "id": "ede62bd739b408995d198e5b24565065",
      "bel": "p(hgnc:6876 ! MAPK14)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK3",
        "identifier": "6877"
      },
      "id": "6dd741794d73ab1e916725d3d79849b7",
      "bel": "p(hgnc:6877 ! MAPK3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CIITA",
        "identifier": "7067"
      },
      "id": "c36b585f1f8794fe36ea65a678b04ce6",
      "bel": "p(hgnc:7067 ! CIITA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL9",
        "identifier": "7098"
      },
      "id": "381972d193eb1b738dac49f3af41d1b5",
      "bel": "p(hgnc:7098 ! CXCL9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MMP12",
        "identifier": "7158"
      },
      "id": "8246826d8afef202b2181e0b35d7a4ae",
      "bel": "p(hgnc:7158 ! MMP12)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MYD88",
        "identifier": "7562"
      },
      "id": "a66b4f47c38485fdb26a921e52772507",
      "bel": "p(hgnc:7562 ! MYD88)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFE2L2",
        "identifier": "7782"
      },
      "id": "0e5a135eddf63c61ede864acab3a682f",
      "bel": "p(hgnc:7782 ! NFE2L2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKB1",
        "identifier": "7794"
      },
      "id": "fb631cdd688dc0faeec8f219cae55fb8",
      "bel": "p(hgnc:7794 ! NFKB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKB2",
        "identifier": "7795"
      },
      "id": "74edda87fa21f94aa6594b9bca0dc600",
      "bel": "p(hgnc:7795 ! NFKB2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "id": "00d5e69a95ae1215066cce653d9249d5",
      "bel": "p(hgnc:7797 ! NFKBIA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 32
        }
      ],
      "id": "b7a1888e9d86a9e2ea68c2fabdb501bf",
      "bel": "p(hgnc:7797 ! NFKBIA, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 32))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 36
        }
      ],
      "id": "bd2a5debda128ab761b0a6ed3177458a",
      "bel": "p(hgnc:7797 ! NFKBIA, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 36))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIE",
        "identifier": "7799"
      },
      "id": "d6a3e8f0f105ec220ac7ec13f12cf736",
      "bel": "p(hgnc:7799 ! NFKBIE)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PPARA",
        "identifier": "9232"
      },
      "id": "6ec335b16b97c1cffba83bb911ab1da9",
      "bel": "p(hgnc:9232 ! PPARA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTK2B",
        "identifier": "9612"
      },
      "id": "6f8d87aa7b22bcd0d24b93620ff905cd",
      "bel": "p(hgnc:9612 ! PTK2B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "REL",
        "identifier": "9954"
      },
      "id": "26d182db0899e6bcdbf4bcc98c9908a3",
      "bel": "p(hgnc:9954 ! REL)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RELA",
        "identifier": "9955"
      },
      "id": "b21bc29a07e8a2299916f8a95bdd0528",
      "bel": "p(hgnc:9955 ! RELA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RELB",
        "identifier": "9956"
      },
      "id": "5d57a39d82836535cb07ef932751096d",
      "bel": "p(hgnc:9956 ! RELB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RFX5",
        "identifier": "9986"
      },
      "id": "85fda88ed0738100e3006dae5b54b13b",
      "bel": "p(hgnc:9986 ! RFX5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "mgi",
        "name": "Il2rg",
        "identifier": "96551"
      },
      "id": "afe6378d9984657664c56637856c850e",
      "bel": "p(mgi:96551 ! Il2rg)"
    }
  ],
  "links": [
    {
      "line": 230,
      "relation": "directlyIncreases",
      "evidence": "The list of endogenous TLR2 and 4 activators has expanded quickly and encompasses other intracellular molecules such as heat shock proteins including HSP70, Gp96 [15-17], HSP22, and HSP72 [18, 19] and high-mobility group box-1 protein (HMGB1) [20-22] as well as ECMmolecules such as biglycan [23], tenascin-C [24], versican [25], and fragments of ECM molecules including oligosaccharides of hyaluronic acid (HA) [26] and heparan sulfate (HS) [27].",
      "citation": {
        "db": "PubMed",
        "db_id": "20706656"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 1,
      "target": 45,
      "key": "00da4a917c0fe35314ed072b4a2a302e"
    },
    {
      "line": 230,
      "relation": "directlyIncreases",
      "evidence": "Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16891671"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 1,
      "target": 45,
      "key": "d0b2c1face89641aadb4123e6a78b5f3"
    },
    {
      "line": 194,
      "relation": "decreases",
      "evidence": "Consistent with the effects of leukotriene antagonists, exogenous LTB(4) enhanced LPS-stimulated IL-10 release by approximately 39% and inhibited IL-12 p40 release by approximately 22%",
      "citation": {
        "db": "PubMed",
        "db_id": "16313356"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 0,
      "target": 93,
      "key": "ff885aaab289304e3df43388b504a4a6"
    },
    {
      "line": 195,
      "relation": "directlyIncreases",
      "evidence": "Leukotriene B4, a potent chemotactic agent that initiates, coordinates, sustains and amplifies the inflammatory response, is shown to be an activating ligand for the transcription factor PPARalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "8900274"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 0,
      "target": 124,
      "key": "1f7cb26c6da6c3640070edac4e0c2d7a"
    },
    {
      "line": 195,
      "relation": "directlyIncreases",
      "evidence": "Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.",
      "citation": {
        "db": "PubMed",
        "db_id": "16313356"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 0,
      "target": 124,
      "key": "75725eb5af25f692e1c27d4a5273c40f"
    },
    {
      "line": 195,
      "relation": "directlyIncreases",
      "evidence": "hypolipidemic fibrates and eicosanoids such as leukotriene B4 and 8(S)-hydroxyeicosatetraenoic acid (8(S)-HETE) are synthetic and natural ligands respectively for PPARa.",
      "citation": {
        "db": "PubMed",
        "db_id": "11852057"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 0,
      "target": 124,
      "key": "cff7c9b263d587c0747f5e69c2ec1043"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "These effects (TLR2,3,5,6 activation of VEGF and IL8) were prevented by treatment with a selective inhibitor of EGFR phosphorylation (AG-1478), a metalloprotease (MP) inhibitor, a reactive oxygen species (ROS) scavenger, and an NADPH oxidase inhibitor.",
      "citation": {
        "db": "PubMed",
        "db_id": "18375743"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "source": 3,
      "target": 100,
      "key": "8c0a93bea4e4cb829a6e6234870a6d0a"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "Cigarette smoke extract induced a significant increase in CXCL8/IL8 production by immature DCs (Figure 2C, 27.3 ± 0.4 vs 183.9 ± 14.9 pg/ml of CXCL8 respectively, p<0.001). Pre-incubation with NAC effectively inhibited the CSE-induced CXCL8 production by DCs (Figure 2C, p<0.001). Pre-treatment of DCs with 2.5mM NAC also significantly suppressed CXCL8 production by DCs stimulated with a combination of LPS and 2% CSE (Figure 2C, p<0.001). In contrast, pre-treatment of DCs with NAC failed to suppress CXCL8/IL-8 generation by LPS-activated DCs. Taken together, these data imply that oxidative stress induced by CSE is an important mechanism by which CXCL8/IL-8 is induced in immature and maturing DCs, whereas nicotinic receptor stimulation is not.",
      "citation": {
        "db": "PubMed",
        "db_id": "18533267"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 3,
      "target": 100,
      "key": "02dc9781627e653a171600784ecbbc29"
    },
    {
      "line": 91,
      "relation": "increases",
      "evidence": "Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS)",
      "citation": {
        "db": "PubMed",
        "db_id": "19293939"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 3,
      "target": 31,
      "key": "fda4bb64304dcee4b8031c889402018a"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS)",
      "citation": {
        "db": "PubMed",
        "db_id": "19293939"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 3,
      "target": 83,
      "key": "57eeec52e0c70f9369fbc0dee7607fa8"
    },
    {
      "line": 117,
      "relation": "increases",
      "evidence": "MD-2 physically associated with TLR2, but this association was weaker than with TLR4.",
      "citation": {
        "db": "PubMed",
        "db_id": "11160242"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 43,
      "key": "62786cddf41b809d825aed46b244dc70"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "LPS, which ligates TLR-4, preferentially upregulated MICA and not MICB......LPS preferentially upregulated MICAand not MICB,CL097 stimulation resulted in upregulation of both MICA and MICB, and poly(I:C) upregulated neither (Fig. 1A, 1B).",
      "citation": {
        "db": "PubMed",
        "db_id": "20488792"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "16a31e55bae2840826160ff98e691d98"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "Lipopolysaccharides (LPS), which activate Toll-like receptor 4 (TLR4), reduced PPARgamma expression and function in peritoneal macrophages and macrophage cell lines",
      "citation": {
        "db": "PubMed",
        "db_id": "18422969"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "500dd2c84ab3b1239afc28d6b9308e58"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "In response to lipopolysaccharide (LPS) exposure, macrophages activate the transcription of a large number of pro-inflammatory genes by way of signaling pathways downstream of the LPS receptor, Toll-Like Receptor 4.",
      "citation": {
        "db": "PubMed",
        "db_id": "15107417"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "4703fd45dc8ab89cf238d2d65b22adb7"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "Finally, we show that Syk associates with Toll-like receptor 4 (TLR4) upon LPS stimulation further implicating Syk in the LPS-induced signaling pathway in neutrophils.",
      "citation": {
        "db": "PubMed",
        "db_id": "14699155"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "0660374f260daf7bc3f12d55bf9a2a24"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "lipopolysaccharide (LPS; endotoxin) from Gram-negative bacteria, which stimulates TLR4; bacterial lipoproteins and lipotechoic acid and fungal zymosan, which stimulate TLR1, TLR2 and TLR6; bacterial flagellin, which activates TLR5; a profilin-like molecule from the protozoan Toxoplasma gondii, which activates TLR11; unmethylated CpG motifs present in DNA that function as stimulators of TLR9; double-stranded RNA that activates TLR3; and singlestranded RNA that can stimulate TLR7 and TLR8",
      "citation": {
        "db": "PubMed",
        "db_id": "19052556"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "12150ab78e26fbe94907efb607af26a9"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "Prototypic examples of PAMPs include lipopolysaccharide (LPS), a outer membrane component of Gram-negative bacteria that stimulates TLR4 [8,9], bacterial lipoproteins that stimulate TLR2 in conjunction with either TLR1 or TLR6 [10], and flagellin, the protein monomer of bacterial flagella that activates TLR5 [11]. Nucleic acids are recognized by endosomal TLRs; double-stranded DNA with unmethylated CpG motifs activates TLR9 in a host species-specific manner while TLR3 and TLR7/8 are activated by dsRNA including synthetic poly (I:C) [12] and ssRNA, respectively [13,14].",
      "citation": {
        "db": "PubMed",
        "db_id": "21108806"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "646ff59ca64ab100658f98be4e907d3c"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "From Full Paper Introduction The TLRs agonist include LPS for Tlr4, peptidglycan for Tlr2 and 6...",
      "citation": {
        "db": "PubMed",
        "db_id": "12865424"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "d32bc752502d66daad035e45604b6cbd"
    },
    {
      "line": 118,
      "relation": "directlyIncreases",
      "evidence": "LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappaB-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "17952090"
      },
      "annotations": {
        "cl": {
          "0000632": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 45,
      "key": "b3c230c3d5fc14b3b4e90457cc3e0a1a"
    },
    {
      "line": 240,
      "relation": "increases",
      "evidence": "Furthermore, IL-15 itself was able to activate DCs, as in vivo or in vitro exposure of splenic DCs to IL-15 resulted in an up-regulation of costimulatory molecules, markedly increased production of IFN-γ by DC and an enhanced ability of DCs to stimulate Ag-specific CD8+ T cell proliferation",
      "citation": {
        "db": "Other",
        "db_id": "11466332"
      },
      "annotations": {},
      "source": 6,
      "target": 94,
      "key": "3017590fdf4b882f71e674c3557b0162"
    },
    {
      "line": 98,
      "relation": "increases",
      "evidence": "Stimulation of DCs with different concentrations of H. pylori for 8, 24, 48, and 72 h resulted in dose-dependent interleukin-6 (IL-6), IL-8, IL-10 and IL-12 production...We observed IL-6, IL-10, and IL-12p70 production, as well as IL-8 release, after the stimulation of DCs with H. pylori.",
      "citation": {
        "db": "PubMed",
        "db_id": "15271898"
      },
      "annotations": {},
      "source": 4,
      "target": 15,
      "key": "1a79d0b78c3a3ffa7dea28e6ea7b1c4a"
    },
    {
      "line": 98,
      "relation": "increases",
      "evidence": "We demonstrate that ligation of either CD40 or MHC class II molecules independently trigger IL-12 production in DC...ELISA specific for the p70 heterodimer were used to determine IL-12 production",
      "citation": {
        "db": "PubMed",
        "db_id": "8760828"
      },
      "annotations": {},
      "source": 4,
      "target": 15,
      "key": "51a559c8ec326197ac508dbccc8c07a5"
    },
    {
      "line": 100,
      "relation": "increases",
      "evidence": "Stimulation of DCs with different concentrations of H. pylori for 8, 24, 48, and 72 h resulted in dose-dependent interleukin-6 (IL-6), IL-8, IL-10 and IL-12 production",
      "citation": {
        "db": "PubMed",
        "db_id": "15271898"
      },
      "annotations": {},
      "source": 4,
      "target": 100,
      "key": "4068cdf0175a1b3fc2d16ce3f20c8da1"
    },
    {
      "line": 243,
      "relation": "association",
      "evidence": "Osteopontin functionally activates dendritic cells and induces their differentiation\ntoward a Th1-polarizing phenotype",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 4,
      "target": 39,
      "key": "16ce0270b57870f9017debb4f1d1c215"
    },
    {
      "line": 121,
      "relation": "increases",
      "evidence": "In this study, we show that C1q mediates the chemotaxis and transendothelial migration of immature MoDC. Additionally, C1q significantly enhances the chemotaxis of LPS-induced mature DC to CCL19 via upregulation of CCR7 expression",
      "citation": {
        "db": "PubMed",
        "db_id": "18838169"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 12,
      "target": 65,
      "key": "e1f02da3d4a0ffc577084e79c7cf2169"
    },
    {
      "line": 107,
      "relation": "directlyIncreases",
      "evidence": "The IKK immunoprecipitates from thrombin-treated cells showed increased phosphorylation of GST-IkBalpha compared with the immunoprecipitates from control cells (Fig. 6), indicating the activation of IKK by thrombin.",
      "citation": {
        "db": "PubMed",
        "db_id": "15843586"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 10,
      "target": 122,
      "key": "8e0bdc5d22071968c64a82b5003fc6cd"
    },
    {
      "line": 107,
      "relation": "directlyIncreases",
      "evidence": "In the classical NF-{kappa}B signaling pathway, IKK{beta} is both necessary and sufficient for phosphorylation of I{kappa}B{alpha} on Ser 32 and Ser 36, and I{kappa}B{beta} on Ser 19 and Ser 23.",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 10,
      "target": 122,
      "key": "d1eac546f6cc0a3d618ea28cf9ae0d15"
    },
    {
      "line": 108,
      "relation": "directlyIncreases",
      "evidence": "The IKK immunoprecipitates from thrombin-treated cells showed increased phosphorylation of GST-IkBalpha compared with the immunoprecipitates from control cells (Fig. 6), indicating the activation of IKK by thrombin.",
      "citation": {
        "db": "PubMed",
        "db_id": "15843586"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 10,
      "target": 121,
      "key": "29f3ffb3beccf1ae3b6520d6e1d1cb04"
    },
    {
      "line": 108,
      "relation": "directlyIncreases",
      "evidence": "In the classical NF-{kappa}B signaling pathway, IKK{beta} is both necessary and sufficient for phosphorylation of I{kappa}B{alpha} on Ser 32 and Ser 36, and I{kappa}B{beta} on Ser 19 and Ser 23.",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 10,
      "target": 121,
      "key": "17755f2f4da1751cc4f1e32eecaa1b2e"
    },
    {
      "line": 149,
      "relation": "increases",
      "evidence": "Toll-like receptors (TLRs) signal through two main pathways: a myeloid differentiation factor (MyD)88-dependent pathway that acts via nuclear factor kappaB (NF-kappaB) to induce proinflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha); In this study we have shown that, whilst NF-kappaB activation and production of TNF-alpha and interleukin-12 by murine RAW264.7 and J774.2 cells in response to stimulation by TLR4, -5, -7 or -9,",
      "citation": {
        "db": "PubMed",
        "db_id": "17034424"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 13,
      "target": 92,
      "key": "0cd4ecf4a51506e1a697db30374ec243"
    },
    {
      "relation": "hasComponent",
      "source": 13,
      "target": 127,
      "key": "d7946658060d248bd232e82ba1dce8c5"
    },
    {
      "line": 244,
      "relation": "increases",
      "evidence": "Collectively, these data demonstrate that in PMN and monocytes inflammatory stimuli sustain the NF-\u0001B-dependent transactivation of C1orf61 locus and consequent production of pri-miR-9–1.",
      "citation": {
        "db": "Other",
        "db_id": "19289835"
      },
      "annotations": {},
      "source": 13,
      "target": 16,
      "key": "92d6fa4d4057981943cc36ac75b6d236"
    },
    {
      "line": 22,
      "relation": "increases",
      "evidence": "we demonstrate that DCs induce IFN-_ secretion of CD56brightCD16- NK cells through IL-12",
      "citation": {
        "db": "PubMed",
        "db_id": "15536127"
      },
      "annotations": {},
      "source": 15,
      "target": 8,
      "key": "888bb0c61071ebf17a4319a4b3a05f36"
    },
    {
      "relation": "partOf",
      "source": 92,
      "target": 15,
      "key": "2ab6f7aa8f053a0329c3d0f1dbc66d3d"
    },
    {
      "relation": "partOf",
      "source": 93,
      "target": 15,
      "key": "258cefef78c78bf2a6729c6f24297a1f"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "Blocking AKT activity prevents NF-kappaB activation",
      "citation": {
        "db": "PubMed",
        "db_id": "12409315"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "fc264be3ad158d03c6315441670acd7a"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "PKC theta selectively cooperated with Akt1, known to act downstream of CD28 co-receptor signaling, in activating a NF-kappa B reporter in T cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "11410591"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "2a412fd52712188584e7ec0ebe3f3730"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "These results indicate that NADPH oxidase (CYBB catalytic subunit)-derived ROS play an important role in NF-kB activation by promoting Akt and NIK phosphorylation and PTEN oxidation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18620044"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "ced2667a25af229be1de6f26fcd0fd51"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "However, in response to activated Akt, the IKKb-/- cells were deficient in NF-kB-dependent transcriptional activation, and, furthermore, reintroduction of IKKb by transfection restored this activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "11259436"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "025691300d462c8d4c3a356ab02d0461"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "Our data demonstrate that fibronectin mRNA expression and protein production that are induced by high glucose are mediated via activation of Akt/PKB, which is modulated by mitogen-activated protein kinase, phosphatidylinositol 3-kinase, and protein kinase C. Glucose-induced fibronectin mRNA expression and protein production are also mediated by Akt1/PKBalpha-dependent activation of the transcription factors nuclear factor-kappaB and activating protein-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "16193290"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "84de7b81f1948e3f19697aaf76b042e8"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "Akt selectively triggers NFkB p65/RelA heterodimer activation to coordinate monocyte and neutrophil recruitment in response to smoke and infection.",
      "citation": {
        "db": "PubMed",
        "db_id": "18046900"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "23853199ca8c6d8560b4b0307d09315f"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "YC-1, in a cGMP-independent manner, inhibited lipopolysaccharide-induced Akt activation, IkappaBalpha degradation and NF-kappaB translocation, all of which are associated with co-stimulatory molecules expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "17673145"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "b92c554a6ca4412d771a5c4265df7ae0"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "Analysis of human or mouse DC treated with the B7-DC cross-linking Ab revealed PI3K-dependent phosphorylation of AKT accompanied by mobilization of NF-kappaB.",
      "citation": {
        "db": "PubMed",
        "db_id": "17237390"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "9c3c32c9118331f46be013516f8640e8"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade.",
      "citation": {
        "db": "PubMed",
        "db_id": "11290748"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 13,
      "key": "c5f441e8be0783f5dc70ec384ee2d1c4"
    },
    {
      "line": 134,
      "relation": "increases",
      "evidence": "However, C3a had a direct migratory effect on MoDC, as indicated by the induction of F-actin polymerization and migration in Boyden chamber experiments, which was pronounced after up-regulation of the C3aR with IFN-alpha+ IFN-gamma.",
      "citation": {
        "db": "PubMed",
        "db_id": "15056381"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 55,
      "target": 7,
      "key": "f5d7690725911676d2083626859ab1d0"
    },
    {
      "line": 42,
      "relation": "increases",
      "evidence": "C5a induced F-actin polymerization was increased when C5aR was up-regulated by PGE2.",
      "citation": {
        "db": "PubMed",
        "db_id": "14632643"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 57,
      "target": 7,
      "key": "a7c2fdc0ae10f0e529a24795be008652"
    },
    {
      "line": 48,
      "relation": "increases",
      "evidence": "Here we report that CCL16 activates an angiogenic program in vascular endothelial cells by activating CCR1.",
      "citation": {
        "db": "PubMed",
        "db_id": "12958070"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 26,
      "target": 60,
      "key": "35e59594cbd6af30ad5adce14cebdcce"
    },
    {
      "line": 41,
      "relation": "increases",
      "evidence": "Using a transient transfection approach in a mature B cell line, 2PK3, we demonstrate that RGS1 and RGS3s are effective inhibitors of chemotaxis toward the lymphoid tissue chemokines stromal cell-derived factor-1, B lymphocyte chemoattractant, and EBV-induced molecule 1 ligand chemokine, whereas RGS2 has a minimal effect on migration to these chemokines.",
      "citation": {
        "db": "PubMed",
        "db_id": "10779778"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 27,
      "target": 65,
      "key": "bd9ba9f4e6aed100179411945d6dfe9b"
    },
    {
      "line": 41,
      "relation": "increases",
      "evidence": "We have found that CXCL13 and CCL19 together by means of activation of CXCR5 and CCR7 up-regulate PEG10 expression and function",
      "citation": {
        "db": "PubMed",
        "db_id": "17082584"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 27,
      "target": 65,
      "key": "5ee08e9a2c53581f407f26772d969367"
    },
    {
      "line": 41,
      "relation": "increases",
      "evidence": "The mechanism by which CCL19 activates ERK1/2 was determined to be beta-arrestin-dependent, because it is reduced both by depletion of beta-arrestin-2 with small interfering RNA and by elimination of the phosphorylation sites in the tail of the receptor",
      "citation": {
        "db": "PubMed",
        "db_id": "15054093"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 27,
      "target": 65,
      "key": "1335e8cfdd29f1085331068146de8b99"
    },
    {
      "line": 162,
      "relation": "directlyIncreases",
      "evidence": "Simvastatin-treated monocytes showed little chemotaxis movement in response to monocyte chemoattractant protein-1 (MCP-1), a specific CCR2 ligand.",
      "citation": {
        "db": "PubMed",
        "db_id": "15781755"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 61,
      "key": "7649f00bb0fa0475944e9d4e5164932d"
    },
    {
      "line": 162,
      "relation": "directlyIncreases",
      "evidence": "MCP-1 binds both to CCR2 and CCR9 but appears to signal only through the former (Charo et al., 1994; Nibbs et al., 1997).",
      "citation": {
        "db": "PubMed",
        "db_id": "9734366"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 61,
      "key": "847e40291994f3d60d75beb53e4dbbe3"
    },
    {
      "line": 162,
      "relation": "directlyIncreases",
      "evidence": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
      "citation": {
        "db": "PubMed",
        "db_id": "19028258"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 61,
      "key": "b88cf02ef1c5e18ad2ded9d7911b173a"
    },
    {
      "line": 162,
      "relation": "directlyIncreases",
      "evidence": "In addition, we found that MCP-1 has a novel function in airway epithelium, increasing the two major airway mucins MUC5AC and MUC5B, an effect mediated, at least in part, by a cascade of events initiated by interaction of its receptor CCR2B with G(q) subunits in caveolae, followed by PLC??, PKC, and (44/42)MAPK activation. We also have shown that MCP-1 is able to induce its own expression using the same receptor but through a different pathway that involves RhoA GTPase.",
      "citation": {
        "db": "PubMed",
        "db_id": "21097527"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 61,
      "key": "e141ac116d57774add2d294c6ab6ad29"
    },
    {
      "line": 154,
      "relation": "increases",
      "evidence": "The mechanism by which CCL19 activates ERK1/2 was determined to be beta-arrestin-dependent, because it is reduced both by depletion of beta-arrestin-2 with small interfering RNA and by elimination of the phosphorylation sites in the tail of the receptor",
      "citation": {
        "db": "PubMed",
        "db_id": "15054093"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 30,
      "target": 65,
      "key": "9ea6b0bb9d70e71bf44ebd84dae70725"
    },
    {
      "line": 197,
      "relation": "directlyIncreases",
      "evidence": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
      "citation": {
        "db": "PubMed",
        "db_id": "19028258"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 31,
      "target": 63,
      "key": "43efb3f5cda4e14c62aa0fdf43cac442"
    },
    {
      "line": 198,
      "relation": "directlyIncreases",
      "evidence": "MIP1alpha is released by macrophages and has chemotactic activity for monocytes and neutrophils via CCR1.",
      "citation": {
        "db": "PubMed",
        "db_id": "15602009"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 31,
      "target": 60,
      "key": "b8b06d7f97f3c9b6b052bf8c810d8594"
    },
    {
      "line": 198,
      "relation": "directlyIncreases",
      "evidence": "In vivo, different chemokines orchestrate the recruitment of  DCs into the lung depending on the inflammatory stimulus present.  In a rat model of inhaled heat-killed Moraxella catarrhalis,  the phenomenon seemed dependent on the expression of CCR1 and  CCR5, which are receptors for the chemokines CCL5 (regulated  on activation, normal T-cell expressed and secreted [RANTES])  and/or CCL3 (macrophage inflammatory protein [MIP]-1{alpha}) produced at the airway level",
      "citation": {
        "db": "PubMed",
        "db_id": "15879415"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 31,
      "target": 60,
      "key": "abb127bf4a8f937704c29df676b8e7ae"
    },
    {
      "line": 198,
      "relation": "directlyIncreases",
      "evidence": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
      "citation": {
        "db": "PubMed",
        "db_id": "19028258"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 31,
      "target": 60,
      "key": "b21ee15d5f9164cb6afc2da5ecd83c9a"
    },
    {
      "line": 111,
      "relation": "increases",
      "evidence": "Taken together, these results showed that MIP- 1b released from ET-1–treated PBMs was biologically functional in mediating chemotaxis of THP-1 cells via the CCR5 receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "20952681"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 32,
      "target": 63,
      "key": "2dd67549f50cb9aee1c693c399c69814"
    },
    {
      "line": 111,
      "relation": "increases",
      "evidence": "Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "10747947"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 32,
      "target": 63,
      "key": "11c44892feda3444abd292032380bde7"
    },
    {
      "line": 111,
      "relation": "increases",
      "evidence": "The CCR5 chemokine receptor is a member of the G protein-coupled receptor (GPCR) family that is expressed by macrophages, memory T-lymphocytes and dendritic cells and is activated by chemotactic proteins (e.g. MIP-1alpha [CCL3], MIP-1beta [CCL4] and RANTES [CCL5])",
      "citation": {
        "db": "PubMed",
        "db_id": "18223665"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 32,
      "target": 63,
      "key": "6dbcd042d8c97be9a4c5eaee7f780db0"
    },
    {
      "line": 111,
      "relation": "increases",
      "evidence": "Table 1.  Lymphoid chemokine receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "15102365"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 32,
      "target": 63,
      "key": "6409f1cfcb580df1343fa7318b545d86"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
      "citation": {
        "db": "PubMed",
        "db_id": "19028258"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 63,
      "key": "33688440d048e33f004242733dc2b7d5"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "In vivo, different chemokines orchestrate the recruitment of  DCs into the lung depending on the inflammatory stimulus present.  In a rat model of inhaled heat-killed Moraxella catarrhalis,  the phenomenon seemed dependent on the expression of CCR1 and  CCR5, which are receptors for the chemokines CCL5 (regulated  on activation, normal T-cell expressed and secreted [RANTES])  and/or CCL3 (macrophage inflammatory protein [MIP]-1{alpha}) produced at the airway level",
      "citation": {
        "db": "PubMed",
        "db_id": "15879415"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 63,
      "key": "6ac39152d09b7f65f47fd7778e484a0c"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "RANTES treatment of PM1 T cells results in the rapid phosphorylation-activation of CCR5, Jak2, and Jak3. RANTES-inducible Jak phosphorylation is insensitive to pertussis toxin inhibition, indicating that RANTES-CCR5-mediated tyrosine phosphorylation events are not coupled directly to Galpha(i) protein-mediated events. In addition to Jaks, several other proteins are rapidly phosphorylated on tyrosine residues in a RANTES-dependent manner, including the Src kinase p56(lck), which associates with Jak3",
      "citation": {
        "db": "PubMed",
        "db_id": "11278738"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 63,
      "key": "3567f6351340ed6a74460c2fa8c0b871"
    },
    {
      "line": 131,
      "relation": "increases",
      "evidence": "Table 1.  Lymphoid chemokine receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "15102365"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 60,
      "key": "ed4e57e115108c52f6408a1f48b33dd1"
    },
    {
      "line": 131,
      "relation": "increases",
      "evidence": "Using selective receptor antagonist, it was demonstrated that RANTESinduced monocyte arrest is mediated via its receptor CCR1 but not CCR5.",
      "citation": {
        "db": "PubMed",
        "db_id": "12545245"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 60,
      "key": "80aad56d2c7ccf8a1584804535812faf"
    },
    {
      "line": 131,
      "relation": "increases",
      "evidence": "The identification of the heptahelical receptors CXCR1 and CXCR2 for IL-8 and its homologues [14, 15], as well as CCR1 and CCR2 for the CC chemokines MIP-1?/regulated on activation normal T cell expressed and secreted (RANTES; CC ligand 5) and monocyte chemotactic protein (MCP) 1 [16, 17],",
      "citation": {
        "db": "PubMed",
        "db_id": "12545245"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 60,
      "key": "bfd00dbce66d069d1c65e5f62aa7eae3"
    },
    {
      "line": 131,
      "relation": "increases",
      "evidence": "To investigate the regulation of the CCR1 chemokine receptor, a rat basophilic leukemia (RBL-2H3) cell line was modified to stably express epitope-tagged receptor. These cells responded to RANTES (regulated upon activation normal T expressed and secreted), macrophage inflammatory protein-1alpha, and monocyte chemotactic protein-2 to mediate phospholipase C activation, intracellular Ca(2+) mobilization and exocytosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "10734056"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 60,
      "key": "573f3fb802f7f3698d18309e934d3330"
    },
    {
      "line": 77,
      "relation": "increases",
      "evidence": "Table 1.  Lymphoid chemokine receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "15102365"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 34,
      "target": 61,
      "key": "2aa348646a3694353c4b1cb027957909"
    },
    {
      "line": 78,
      "relation": "increases",
      "evidence": "Table 1.  Lymphoid chemokine receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "15102365"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 34,
      "target": 60,
      "key": "a32f6f798bf3201128e710515b74ff36"
    },
    {
      "line": 183,
      "relation": "increases",
      "evidence": "Table 1.  Lymphoid chemokine receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "15102365"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 61,
      "key": "6ada3f29ee221b9e349454fac9ca3d5b"
    },
    {
      "line": 184,
      "relation": "increases",
      "evidence": "Table 1.  Lymphoid chemokine receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "15102365"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 63,
      "key": "8880469a3b9ee9073ebcc27e3d332c8d"
    },
    {
      "line": 185,
      "relation": "increases",
      "evidence": "Table 1.  Lymphoid chemokine receptors",
      "citation": {
        "db": "PubMed",
        "db_id": "15102365"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 60,
      "key": "e9ba52b439ff690ad79aa84832f3d4ee"
    },
    {
      "line": 191,
      "relation": "increases",
      "evidence": "Stimulation with those CCR6 ligands leads to calcium mobilization and elevated active RhoA, phosphorylated myosin light chain, and F-actin accumulation. HBD2 and CCL20 were unable to stimulate migration in the presence of either Rho-kinase or phosphoinositide 3-kinase inhibitors or an intracellular calcium chelator.",
      "citation": {
        "db": "PubMed",
        "db_id": "19233848"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 64,
      "target": 104,
      "key": "de58356856de6caa51de145b3c8164ad"
    },
    {
      "line": 30,
      "relation": "increases",
      "evidence": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 65,
      "target": 109,
      "key": "3ed14c2e71d129fd8f08878b79867b4d"
    },
    {
      "line": 30,
      "relation": "increases",
      "evidence": "The mechanism by which CCL19 activates ERK1/2 was determined to be beta-arrestin-dependent, because it is reduced both by depletion of beta-arrestin-2 with small interfering RNA and by elimination of the phosphorylation sites in the tail of the receptor",
      "citation": {
        "db": "PubMed",
        "db_id": "15054093"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 65,
      "target": 109,
      "key": "6f1f9c9be93a36da648e3590ed3a3d52"
    },
    {
      "line": 31,
      "relation": "increases",
      "evidence": "CCL19 also increased interaction between phospho-JNK and phospho-mitogen-activated protein kinase kinase (MKK) 4 but not phospho-MKK7 in mature DCs, suggesting that the JNK activation is mediated via MKK4",
      "citation": {
        "db": "PubMed",
        "db_id": "16027136"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 65,
      "target": 107,
      "key": "538bee4ea97ca08257352eb9af1e7958"
    },
    {
      "line": 32,
      "relation": "increases",
      "evidence": "CCR7 also induced activation of the GTPase Rho, the tyrosine kinase Pyk2, and inactivation of cofilin. Pyk2 activation was independent of Gi  and Src and was dependent on Rho.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 65,
      "target": 22,
      "key": "d2e57a76947849f3e12e4dcec40ce10d"
    },
    {
      "line": 33,
      "relation": "increases",
      "evidence": "The mechanism by which CCL19 activates ERK1/2 was determined to be beta-arrestin-dependent, because it is reduced both by depletion of beta-arrestin-2 with small interfering RNA and by elimination of the phosphorylation sites in the tail of the receptor",
      "citation": {
        "db": "PubMed",
        "db_id": "15054093"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 65,
      "target": 112,
      "key": "409db548cc086df4605aea3a7e947957"
    },
    {
      "line": 33,
      "relation": "increases",
      "evidence": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 65,
      "target": 112,
      "key": "71a3fd8f2650c26067d22d070d385bf9"
    },
    {
      "line": 34,
      "relation": "increases",
      "evidence": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 65,
      "target": 24,
      "key": "2fd17f48d3fe838205c537ed8c5fff6c"
    },
    {
      "line": 74,
      "relation": "increases",
      "evidence": "This study demonstrates that the engagement of CD40 results in the activation of the recently described IkappaB kinase (IKK) in a human B cell line",
      "citation": {
        "db": "PubMed",
        "db_id": "10229103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 46,
      "target": 10,
      "key": "a0ddd977610e6ae27a70e5ad48f28c61"
    },
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "CD40L-induced TF on vascular SMC is functional and activates coagulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "10623647"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 47,
      "target": 46,
      "key": "5f6879ad6ec2645c0db993872354717d"
    },
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "CD40 ligation of DC also has the capacity to induce high levels of the cytokine IL-12, which polarizes CD4+ T cells toward a T helper 1 (Th1) type, enhances proliferation of CD8+ T cells, and activates NK cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "12906261"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 47,
      "target": 46,
      "key": "4cf92c087c66521a3c0bae67657209df"
    },
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "An alternate mechanism by which DCs are induced to generate IL-12p70 is by activation of the CD40 receptor, following recognition of its ligand CD154 (CD40L).",
      "citation": {
        "db": "PubMed",
        "db_id": "18606709"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 47,
      "target": 46,
      "key": "8f9e5e88d82af98e30fd152cfd0d701d"
    },
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "Stimulation of human primary HUVECs by CD40 with its physiological ligand CD40L not only augmented MMP-1, -9 secretion and promoted MMP-1, -9 activities, but also induced endothelial cell apoptosis and death.",
      "citation": {
        "db": "PubMed",
        "db_id": "18495129"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 47,
      "target": 46,
      "key": "548909a768c6f0c8a60f7885860eec86"
    },
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "We also examined NF-kB activation in response to stimulation of macrophages through the CD40-CD154 receptor-ligand interaction, which has been shown to be closely linked with the formation of atherosclerotic lesions (35). Stimulation of macrophages through CD40",
      "citation": {
        "db": "PubMed",
        "db_id": "15684432"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 47,
      "target": 46,
      "key": "1c32eb26a7fde8d8cf2331dc9b375a61"
    },
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "In addition to leukocyte adhesion, CD40/CD40L interactions, probably in combination with IFN-, foster a Th1 immune response, predominant at sites of atherosclerosis.20",
      "citation": {
        "db": "PubMed",
        "db_id": "11739273"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 47,
      "target": 46,
      "key": "cdc8362217f0073272d5b0339a7d90ee"
    },
    {
      "line": 73,
      "relation": "directlyIncreases",
      "evidence": "A trimeric form of recombinant murine CD40 ligand acts on human EC to increase expression of leukocyte adhesion molecules, including E-selectin, vascular cell adhesion molecule 1, and intercellular adhesion molecule 1",
      "citation": {
        "db": "PubMed",
        "db_id": "7538666"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 47,
      "target": 46,
      "key": "2c5389f3c124f2aa05cfc506b84f6339"
    },
    {
      "line": 218,
      "relation": "decreases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "9520401"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 123,
      "key": "56a6736e2b91eb380388f419a16cad80"
    },
    {
      "line": 29,
      "relation": "directlyDecreases",
      "evidence": "CIITA(-/-) DC activated with LPS or CpG expressed increased IL-10 levels, but normal levels of TNF-alpha and IL-12 relative to control.",
      "citation": {
        "db": "Other",
        "db_id": "15661876"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 113,
      "target": 91,
      "key": "5f29fa522dfb14aa7e4fc5d34a67303d"
    },
    {
      "line": 171,
      "relation": "directlyIncreases",
      "evidence": "In this report, we show that the fractalkine-CX(3)CR1 interaction resulting in recruitment of natural killer (NK) cells and monocyte-macrophages plays an important role in mediating this endothelial damage.",
      "citation": {
        "db": "PubMed",
        "db_id": "17895402"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 78,
      "key": "c4f1334a7aef4b2e277f2ea30acf4ef7"
    },
    {
      "line": 171,
      "relation": "directlyIncreases",
      "evidence": "We transfected CX3CR1-interfering RNA or control siRNA into cultured HUVECs and exposed these cells to s-FKN. HUVECs with CX3CR1 knockdown expressed less ICAM-1 mRNA and protein compared with cells transfected with control siRNA (Figure 4a and 4b), indicating that FKN does activate ICAM-1 in ECs through CX3CR1.",
      "citation": {
        "db": "PubMed",
        "db_id": "17885215"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 78,
      "key": "aed69c5c2f0198e1273bb389d35bd58e"
    },
    {
      "line": 171,
      "relation": "directlyIncreases",
      "evidence": "Membrane-anchored CX3CL1 serves as an adhesion molecule to capture subsets of mononuclear leukocytes that express the sole receptor, CX3CR1. The extracellular chemokine domain of CX3CL1 can be cleaved/shed by a disintegrin and metalloproteinase domain (ADAM) from stimulus-exposed cells..Soluble CX3CL1 chemoattracts and activates CX3CR1+ leukocytes such as CD8+, CD4+, and T lymphocytes, natural killer (NK) cells, dendritic cells (DC), and mono-cytes [25, 31, 39-45].",
      "citation": {
        "db": "PubMed",
        "db_id": "20827321"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 78,
      "key": "18b86d08cecee2c559408bd1b8bcae1a"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": "We show that CX3CL1 promotes NK activation by mDCs...In contrast, CX3CL1 neutralization led to killer cell immunoglobulin-like receptor (KIR) phosphorylation and SHP-1 recruitment in YTS(KIR2DL1) cultured with HLA-Cw4 mDCs. Moreover, CX3CL1 neutralization promoted dispersion of lipid rafts and the formation of a multiprotein complex required for cytoskeletal rearrangements in YTS NK cells. These findings point to a pivotal role of CX3CL1 in the activation of resting NK cells by mature DCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "18682600"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 38,
      "target": 8,
      "key": "c8d7b2ffbe7dec98ac1c10a0160d620f"
    },
    {
      "line": 103,
      "relation": "directlyIncreases",
      "evidence": "By using a CXCR3 ligand reporter mouse, we found that stromal cells predominately expressed the chemokine ligand CXCL9 whereas hematopoietic cells expressed CXCL10 in lymph nodes (LNs). Dendritic cell (DC)-derived CXCL10 facilitated T cell-DC interactions in LNs during T cell priming while both chemokines guided intranodal positioning of CD4(+) T cells to interfollicular and medullary zones. Thus, different chemokines acting on the same receptor can function locally to facilitate DC-T cell interactions and globally to influence intranodal positioning, and both functions contribute to Th1 cell differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "23123063"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 36,
      "target": 82,
      "key": "bc6d5825751d9a73457d82dcda68b872"
    },
    {
      "line": 103,
      "relation": "directlyIncreases",
      "evidence": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
      "citation": {
        "db": "PubMed",
        "db_id": "19028258"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 36,
      "target": 82,
      "key": "d27e4d2ff5c19362e5a885b308b7d83c"
    },
    {
      "line": 103,
      "relation": "directlyIncreases",
      "evidence": "T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.",
      "citation": {
        "db": "PubMed",
        "db_id": "15602009"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 36,
      "target": 82,
      "key": "029d0b32d0c3f8f0849d66037b2fc7ad"
    },
    {
      "line": 67,
      "relation": "directlyIncreases",
      "evidence": "T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.",
      "citation": {
        "db": "PubMed",
        "db_id": "15602009"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 37,
      "target": 82,
      "key": "07e6f81cf00374a2d7e26dbd7eca8b0e"
    },
    {
      "line": 67,
      "relation": "directlyIncreases",
      "evidence": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
      "citation": {
        "db": "PubMed",
        "db_id": "19028258"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 37,
      "target": 82,
      "key": "76af2c8fbf1da4b39f239af74aa2052c"
    },
    {
      "line": 160,
      "relation": "directlyIncreases",
      "evidence": "CXCR6, the receptor for CXCL16",
      "citation": {
        "db": "PubMed",
        "db_id": "14625285"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 67,
      "target": 68,
      "key": "0fff66deaedc2520543540a1d9738cc0"
    },
    {
      "line": 53,
      "relation": "directlyIncreases",
      "evidence": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
      "citation": {
        "db": "PubMed",
        "db_id": "19028258"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 114,
      "target": 82,
      "key": "bde6973514c11183d2c7d99d00a5b76d"
    },
    {
      "line": 53,
      "relation": "directlyIncreases",
      "evidence": "By using a CXCR3 ligand reporter mouse, we found that stromal cells predominately expressed the chemokine ligand CXCL9 whereas hematopoietic cells expressed CXCL10 in lymph nodes (LNs). Dendritic cell (DC)-derived CXCL10 facilitated T cell-DC interactions in LNs during T cell priming while both chemokines guided intranodal positioning of CD4(+) T cells to interfollicular and medullary zones. Thus, different chemokines acting on the same receptor can function locally to facilitate DC-T cell interactions and globally to influence intranodal positioning, and both functions contribute to Th1 cell differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "23123063"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 114,
      "target": 82,
      "key": "456879330f71aace3965c2eeb927dedf"
    },
    {
      "line": 53,
      "relation": "directlyIncreases",
      "evidence": "T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.",
      "citation": {
        "db": "PubMed",
        "db_id": "15602009"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 114,
      "target": 82,
      "key": "22056894bf676cd4227a0947d9bfe902"
    },
    {
      "line": 221,
      "relation": "increases",
      "evidence": "the chemokine Mig, a ligand for CXCR3, activates the small GTPases RhoA and Rac1, induces a reorganization of the actin cytoskeleton, and triggers cell chemotaxis and modulation of integrin VLA-5- and VLA-4-dependent cell adhesion to fibronectin.",
      "citation": {
        "db": "PubMed",
        "db_id": "11571298"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 82,
      "target": 104,
      "key": "e3618633a2d006d5a4852c605e5714ee"
    },
    {
      "line": 17,
      "relation": "directlyIncreases",
      "evidence": "FRET images in RAW264.7 macrophages demonstrated association of HMGB1 with TLR2 and TLR4 but not RAGE. Transient transfections into human embryonic kidney-293 cells showed that HMGB1 induced cellular activation and NF-kappaB-dependent transcription through TLR2 or TLR4 but not RAGE. Coimmunoprecipitation also found interaction between HMGB1 and TLR2 as well as TLR4, but not with RAGE. These studies provide the first direct evidence that HMGB1 can interact with both TLR2 and TLR4 and also supply an explanation for the ability of HMGB1 to induce cellular activation and generate inflammatory responses that are similar to those initiated by LPS.",
      "citation": {
        "db": "PubMed",
        "db_id": "16267105"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 43,
      "key": "e2a8636d9b6c82d056dd724fe5d416d2"
    },
    {
      "line": 17,
      "relation": "directlyIncreases",
      "evidence": "Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16891671"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 43,
      "key": "7afb7dfb9e09a7edb3651a59856f6636"
    },
    {
      "line": 17,
      "relation": "directlyIncreases",
      "evidence": "For example, the high mobility group box protein 1 (HMGB1) protein that normally resides in the cell nucleus can activate TLR2 and induce hallmarks of lupus-like disease when released from apoptotic cells as a complex with nucleosomes [18].",
      "citation": {
        "db": "PubMed",
        "db_id": "21108806"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 43,
      "key": "082773f08d53ec7282ad126fe5dd3571"
    },
    {
      "line": 17,
      "relation": "directlyIncreases",
      "evidence": "The list of endogenous TLR2 and 4 activators has expanded quickly and encompasses other intracellular molecules such as heat shock proteins including HSP70, Gp96 [15-17], HSP22, and HSP72 [18, 19] and high-mobility group box-1 protein (HMGB1) [20-22] as well as ECMmolecules such as biglycan [23], tenascin-C [24], versican [25], and fragments of ECM molecules including oligosaccharides of hyaluronic acid (HA) [26] and heparan sulfate (HS) [27].",
      "citation": {
        "db": "PubMed",
        "db_id": "20706656"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 43,
      "key": "227b84f3f40159dcc6a8b70b7675f13d"
    },
    {
      "line": 18,
      "relation": "directlyIncreases",
      "evidence": "In vivo, extracellular HMGB1 can bind Toll-like receptor 4 on the surface of dendritic cells, de facto operating as a danger-associated molecular pattern and alarming the organism to the presence of stressful conditions.",
      "citation": {
        "db": "Other",
        "db_id": "23733568"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 45,
      "key": "541543da8c415cc773466cc3f0cfbcb0"
    },
    {
      "line": 18,
      "relation": "directlyIncreases",
      "evidence": "The list of endogenous TLR2 and 4 activators has expanded quickly and encompasses other intracellular molecules such as heat shock proteins including HSP70, Gp96 [15-17], HSP22, and HSP72 [18, 19] and high-mobility group box-1 protein (HMGB1) [20-22] as well as ECMmolecules such as biglycan [23], tenascin-C [24], versican [25], and fragments of ECM molecules including oligosaccharides of hyaluronic acid (HA) [26] and heparan sulfate (HS) [27].",
      "citation": {
        "db": "PubMed",
        "db_id": "20706656"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 45,
      "key": "421b75c8d52835f1da50b2a44582c897"
    },
    {
      "line": 18,
      "relation": "directlyIncreases",
      "evidence": "Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16891671"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 45,
      "key": "41c533972dda6aa93cc0bb931b10c74c"
    },
    {
      "line": 18,
      "relation": "directlyIncreases",
      "evidence": "FRET images in RAW264.7 macrophages demonstrated association of HMGB1 with TLR2 and TLR4 but not RAGE. Transient transfections into human embryonic kidney-293 cells showed that HMGB1 induced cellular activation and NF-kappaB-dependent transcription through TLR2 or TLR4 but not RAGE. Coimmunoprecipitation also found interaction between HMGB1 and TLR2 as well as TLR4, but not with RAGE. These studies provide the first direct evidence that HMGB1 can interact with both TLR2 and TLR4 and also supply an explanation for the ability of HMGB1 to induce cellular activation and generate inflammatory responses that are similar to those initiated by LPS.",
      "citation": {
        "db": "PubMed",
        "db_id": "16267105"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 45,
      "key": "a6bfec4ba0380e86221fd27a9a3f6660"
    },
    {
      "relation": "hasVariant",
      "source": 87,
      "target": 88,
      "key": "09b8d15333299a7def87660da0607c47"
    },
    {
      "relation": "hasVariant",
      "source": 87,
      "target": 89,
      "key": "08831b388c3e14449cf4902d6ae04187"
    },
    {
      "line": 133,
      "relation": "directlyDecreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 87,
      "target": 120,
      "key": "c1340a66cee063276389f5e2681039e5"
    },
    {
      "line": 129,
      "relation": "increases",
      "evidence": "The interaction of TRIF and non-canonical IlB kinases IKKe and TANK-binding kinase 1 (TBK1) leads to phosphorylation of IRF-3 by the kinases.",
      "citation": {
        "db": "PubMed",
        "db_id": "19025601"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 58,
      "target": 102,
      "key": "4a61855ed85539ca7dbcd2b3e7b406d1"
    },
    {
      "line": 129,
      "relation": "increases",
      "evidence": "Thus, IKKepsilon and TBK1 have a pivotal role in coordinating the activation of IRF3 and NF-kappaB in the innate immune response (via TLR3 activation).",
      "citation": {
        "db": "PubMed",
        "db_id": "12692549"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 58,
      "target": 102,
      "key": "98582cded7f26e3df17c7443532f0bcb"
    },
    {
      "line": 129,
      "relation": "increases",
      "evidence": "TANK-binding kinase-1 (TBK1) and the inducible IkappaB kinase (IKK-i) have been shown recently to activate interferon (IFN) regulatory factor-3 (IRF3), the primary transcription factor regulating induction of type I IFNs.",
      "citation": {
        "db": "PubMed",
        "db_id": "15210743"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 58,
      "target": 102,
      "key": "1a7de3dd583e5282a2e600a63f9664f0"
    },
    {
      "line": 62,
      "relation": "increases",
      "evidence": "the pro-inflammatory cytokine IL-6 and the anti-inflammatory cytokine IL-10 both activate STAT3, yet generate nearly opposing cellular responses. Here, we show that the temporal pattern of STAT3 activation codes for the specific cytokine response. A computational model of IL-6 and IL-10 signaling predicted that IL-6 stimulation results in transient activation of STAT3, with a rapid decline in phosphorylation and nuclear localization. In contrast, simulated IL-10 signaling resulted in sustained STAT3 activation. The predicted STAT3 patterns produced by each cytokine were confirmed experimentally in human dendritic cells",
      "citation": {
        "db": "Other",
        "db_id": "23166328"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 91,
      "target": 40,
      "key": "c21e29fd28db0252144c73499989d85f"
    },
    {
      "line": 213,
      "relation": "directlyIncreases",
      "evidence": "IL-15 is a common gamma chain cytokine sharing overlapping signaling and biological properties with IL-2 as a result of their mutual usage of the IL-2/15b and common gamma chain (gc) receptor subunits (7,8).",
      "citation": {
        "db": "PubMed",
        "db_id": "21098221"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 94,
      "target": 95,
      "key": "d777ac828f6e61a0d0996650eced5eef"
    },
    {
      "line": 214,
      "relation": "directlyIncreases",
      "evidence": "Interleukin 15 (IL-15) is a 14-15 kDa polypeptide that belongs to the 4 alpha-helix-bundle family of cytokines and was originally discovered due to its T cell proliferative activity. It utilizes the signal-transducing beta/gamma polypeptides of the IL-2 receptor complex, thus sharing many biological activities with IL-2,",
      "citation": {
        "db": "PubMed",
        "db_id": "11197599"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 94,
      "target": 97,
      "key": "2314ef86ace5452f390e6aa3c0b363c6"
    },
    {
      "line": 214,
      "relation": "directlyIncreases",
      "evidence": "Considering these points in the context of IL-2- and IL-15-dependent signaling under physiological conditions, the lack of a cytoplasmic domain for IL-2R alpha and trans-presentation of IL-15 by IL-15Ralpha  to CD122 and gamma C results in a qualitative identical utilization of signaling pathways associated with CD122 and gamma C. High levels of IL-2Ralpha provide a mean for continual capture of IL-2 to sustain signaling whereas limiting IL-15Ralpha tempers engagement of CD122 and gamma C, limiting signal transduction. Thus, varied levels of IL-2Ralpha and IL-15Ralpha provide a simple, yet powerful, mechanism to quantify and tune signaling through common intermediates leading to distinctive biological responses.",
      "citation": {
        "db": "PubMed",
        "db_id": "22447977"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 94,
      "target": 97,
      "key": "7e74d9ada4a10f9764077ae1b4f74749"
    },
    {
      "line": 217,
      "relation": "increases",
      "evidence": "IL-15 mediates NK cell proliferation upon DC encounter. Because DC-induced NK cell proliferation is sensitive to transwell separation, and because the active DCs present IL-15 on their surface, we suggest that membrane-bound IL-15 is the relevant cytokine form for NK cell expansion mediated by DCs.",
      "citation": {
        "db": "Other",
        "db_id": "15536127"
      },
      "annotations": {},
      "source": 94,
      "target": 5,
      "key": "243a8d7ebcb3600d062c212d7af70c17"
    },
    {
      "line": 241,
      "relation": "increases",
      "evidence": "Furthermore, IL-15 itself was able to activate DCs, as in vivo or in vitro exposure of splenic DCs to IL-15 resulted in an up-regulation of costimulatory molecules, markedly increased production of IFN-γ by DC and an enhanced ability of DCs to stimulate Ag-specific CD8+ T cell proliferation",
      "citation": {
        "db": "Other",
        "db_id": "11466332"
      },
      "annotations": {},
      "source": 94,
      "target": 6,
      "key": "ee972c3781e638bb18e73223697b11b4"
    },
    {
      "line": 27,
      "relation": "decreases",
      "evidence": "In addition to its effects on human cells, IL-4 reduced C5a receptors in murine bone marrow-derived DC and impaired recruitment of labeled bone marrow-derived DC in syngeneic BALB/c mice to i.p. injected C5a. Overall, these data suggest that inhibition of a rapid anaphylatoxin-induced mobilization of monocytes and DC to inflamed tissues represents an important anti-inflammatory activity of the Th2 cytokine IL-4.",
      "citation": {
        "db": "PubMed",
        "db_id": "12626590"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 98,
      "target": 55,
      "key": "9b10e686f415004ffe967898e24d2b83"
    },
    {
      "line": 27,
      "relation": "decreases",
      "evidence": "In the present study we investigated the impact of GM-CSF, IL-4, and IFN-gamma on anaphylatoxin receptor expression in monocytes and dendritic cells (DC). IL-4 was identified as the strongest down-regulator of the receptors for C5a and C3a in monocytes and monocyte-derived DC (MoDC).",
      "citation": {
        "db": "PubMed",
        "db_id": "12626590"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 98,
      "target": 55,
      "key": "5d17ba2ed575d772fcf8f6b5498b54ca"
    },
    {
      "line": 28,
      "relation": "decreases",
      "evidence": "In addition to its effects on human cells, IL-4 reduced C5a receptors in murine bone marrow-derived DC and impaired recruitment of labeled bone marrow-derived DC in syngeneic BALB/c mice to i.p. injected C5a. Overall, these data suggest that inhibition of a rapid anaphylatoxin-induced mobilization of monocytes and DC to inflamed tissues represents an important anti-inflammatory activity of the Th2 cytokine IL-4.",
      "citation": {
        "db": "PubMed",
        "db_id": "12626590"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 98,
      "target": 57,
      "key": "5ba79fe4e3bc4882f82f59ffb2e8f03a"
    },
    {
      "line": 28,
      "relation": "decreases",
      "evidence": "In the present study we investigated the impact of GM-CSF, IL-4, and IFN-gamma on anaphylatoxin receptor expression in monocytes and dendritic cells (DC). IL-4 was identified as the strongest down-regulator of the receptors for C5a and C3a in monocytes and monocyte-derived DC (MoDC).",
      "citation": {
        "db": "PubMed",
        "db_id": "12626590"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "source": 98,
      "target": 57,
      "key": "46c799cb5a163314cbf5acfdf8cf436a"
    },
    {
      "line": 126,
      "relation": "increases",
      "evidence": "the pro-inflammatory cytokine IL-6 and the anti-inflammatory cytokine IL-10 both activate STAT3, yet generate nearly opposing cellular responses. Here, we show that the temporal pattern of STAT3 activation codes for the specific cytokine response. A computational model of IL-6 and IL-10 signaling predicted that IL-6 stimulation results in transient activation of STAT3, with a rapid decline in phosphorylation and nuclear localization. The predicted STAT3 patterns produced by each cytokine were confirmed experimentally in human dendritic cells.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 99,
      "target": 40,
      "key": "5ea34987e53bf71ad73a9a16f39786c4"
    },
    {
      "line": 126,
      "relation": "increases",
      "evidence": "IL-6 treatment stimulated lung Stat3 activation and prevented AEC apoptosis",
      "citation": {
        "db": "Other",
        "db_id": "20443866"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 99,
      "target": 40,
      "key": "dab9f99e50f7d64e130a25b240b71c44"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "IRAK-1 activation and recruitment is essential for activation of TRAF6 (TNF-associated factor 6), which is an essential adaptor for MyD88-dependent NF-kB activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 101,
      "target": 48,
      "key": "61250ec4249660ddb7f34141272306bf"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Phosphorylated IRAK1 dissociates from the complex and activates TRAF6.",
      "citation": {
        "db": "PubMed",
        "db_id": "22566960"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 101,
      "target": 48,
      "key": "0d4782efb00638f926a405bdc0d7aa0f"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Except for TLR3, all TLR ligation events recruit the adaptor MyD88, followed by the IRAK family of protein kinases, leading to the activation of TRAF6.",
      "citation": {
        "db": "PubMed",
        "db_id": "20981241"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 101,
      "target": 48,
      "key": "6ddab44902d8e43549e042a09e504388"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined.",
      "citation": {
        "db": "PubMed",
        "db_id": "16951367"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 101,
      "target": 48,
      "key": "a31d6b45b92a39876b188832d5f306f4"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "Schematic representation of NE-induced IL-8 signal transduction pathway in human bronchial epithelial cells. In bronchial epithelial cells, NE activates an as yet unidentified receptor. The cytosolic protein MyD88 acts as an adaptor coupling the receptor complex to IRAK. The signal is relayed downstream via TRAF-6 to the I?B kinases (IKKs) (via NIK/MEKK1), resulting in phosphorylation and degradation of I?B?, and subsequent release and translocation of NF?B to the nucleus where it transactivates IL-8 gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "11461907"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 101,
      "target": 48,
      "key": "74ffa9fc6f1c830469c83b6f02b4ad20"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "small interfering RNA silencing of TRAF6 expression inhibited MyD88-induced and IRAK-1-induced activation, and supplementation with the TRAF6 dominant-negative mutant did not restore the IRAK-1-induced activation. Expression of IRAK-1, but not MyD88, induced the oligomerization of TRAF6",
      "citation": {
        "db": "PubMed",
        "db_id": "18070982"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 101,
      "target": 48,
      "key": "45728645a004e6c67e4e073b4b81d42f"
    },
    {
      "line": 75,
      "relation": "increases",
      "evidence": "MyD88 promotes association with IRAK4 and IRAK1.  During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK1, which then induces interaction of TRAF6 with the complex.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 72,
      "target": 101,
      "key": "80e5c3e6a7d160532f3ea264713c7ff8"
    },
    {
      "line": 75,
      "relation": "increases",
      "evidence": "Then, IRAK4 activates IRAK1 and IRAK2.",
      "citation": {
        "db": "PubMed",
        "db_id": "22661952"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 72,
      "target": 101,
      "key": "23237c36c8f748c421c10b69e8e95895"
    },
    {
      "line": 75,
      "relation": "increases",
      "evidence": "In this report, we demonstrate that IRAK-4 is recruited to the IL-1R complex upon IL-1 stimulation and is required for the recruitment of IRAK-1 and its subsequent activation/degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15292196"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 72,
      "target": 101,
      "key": "7c75ae92f535015e813b149cb924df8c"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Triggering of p38 activated DCs substantially enhanced the antitumor immune response and prolonged survival of tumor-bearing mice. Activation of extracellular signal-regulated kinase (ERK) increased TGF-beta expression while expression of a constitutively activated interferon regulatory factor-3 (IRF3) stimulated IL-10 secretion by DCs. ERK and IRF3 suppressed the immune response and stimulated expansion of regulatory T cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "18180378"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 102,
      "target": 91,
      "key": "14c95217b7023c1d6d8b483686292846"
    },
    {
      "line": 167,
      "relation": "increases",
      "evidence": "we demonstrate that overexpression of IRF-3 significantly enhances virus-mediated transcription of the IFNA and IFNB genes in infected cells as well as IFN synthesis",
      "citation": {
        "db": "PubMed",
        "db_id": "9707562"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 102,
      "target": 86,
      "key": "6020636ce97c3f79a45c9323e968007c"
    },
    {
      "line": 39,
      "relation": "directlyIncreases",
      "evidence": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "16729045"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 107,
      "target": 20,
      "key": "b4da19b9dfc496c6e9ad58e29833b1bc"
    },
    {
      "line": 157,
      "relation": "directlyIncreases",
      "evidence": "TAK1 can also activate IkappaB kinase (IKK) that leads to degradation of IkappaB and subsequent NF-kappaB activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16893890"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 108,
      "target": 10,
      "key": "58ad2b721c1973640cc6a4f759821340"
    },
    {
      "line": 158,
      "relation": "increases",
      "evidence": "The IRAK4:IRAK1:TRAF6 complex then interacts at the membrane with another preformed complex consisting of TAK1, TAB1 and TAB2.  This interaction induces phosphorylation of TAB2 and TAK1.  TAK1 is subsuequently activated in the cytoplasm, leading to the activation of IKK.  Activation leads to phosphorylation and degradation of IKB and consequent release of NFKB. Activation of TAK1 also results in the activation of MAP kinases and JNK.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 108,
      "target": 77,
      "key": "5e03c8438da60021fb14d705657e9d2c"
    },
    {
      "line": 159,
      "relation": "increases",
      "evidence": "TAK1-induced iNOS-Luc activity was substantially inhibited by pharmacological inhibitors of the known downstream kinases, p38 MAPK and JNK (SB203580 and SP620125), and was almost completely blocked by co-expression of a phosphorylation mutant of IkappaB. TAK1/TAB1 also induced the production of NO and the expression of iNOS in microglial cells in a p38 MAPK-, JNK- and NFkappaB-dependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "12969270"
      },
      "annotations": {
        "cl": {
          "0000125": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 108,
      "target": 24,
      "key": "8e31ac78b4b6eff2dcb5cad79e3684e1"
    },
    {
      "line": 159,
      "relation": "increases",
      "evidence": "ER81 is not only activated by ERK MAPK but also by p38 MAPK (42, 68). TAK1 is an MAPK kinase kinase that is capable of activating the p38 MAPK pathway (39, 69-73),",
      "citation": {
        "db": "PubMed",
        "db_id": "12947087"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 108,
      "target": 24,
      "key": "837d32fe139e584aeac768fa59ca2e10"
    },
    {
      "line": 159,
      "relation": "increases",
      "evidence": "TAK1 is thought to activate two divergent pathways that lead to the transcription factors NF-kB and AP-1 through kinase cascades involving the canonical I?B kinase complex (IKK-a, IKK-b, and IKK-g) and MAP kinases (ERK, JNK, p38), respectively, to induce the expression of target genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15642149"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 108,
      "target": 24,
      "key": "347740c740969350b9fa28bc60fcbb8d"
    },
    {
      "line": 156,
      "relation": "increases",
      "evidence": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 109,
      "target": 20,
      "key": "f4c0df298ef837c975d73fbffedc26db"
    },
    {
      "line": 124,
      "relation": "increases",
      "evidence": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 112,
      "target": 20,
      "key": "9a747f6a7da9d26237ce15a6ddb72610"
    },
    {
      "line": 137,
      "relation": "directlyIncreases",
      "evidence": "MyD88 promotes association with IRAK4 and IRAK1.  During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK1, which then induces interaction of TRAF6 with the complex.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 116,
      "target": 72,
      "key": "f299f34e02a5611037cb2f9873f06459"
    },
    {
      "line": 64,
      "relation": "decreases",
      "evidence": "Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants.",
      "citation": {
        "db": "PubMed",
        "db_id": "12968018"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 3,
      "key": "b78685bc9c02137d92c4479f24c7e04a"
    },
    {
      "line": 64,
      "relation": "decreases",
      "evidence": "Sulforaphane induces via activation of the Nrf2/Keap1 system phase 2 enzymes that protect against carcinogens and oxidants.",
      "citation": {
        "db": "PubMed",
        "db_id": "17015256"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 3,
      "key": "30c5887aef14c91b8ade702edd913b55"
    },
    {
      "line": 64,
      "relation": "decreases",
      "evidence": "Moreover, despite their elevated levels of ROS, Nrf2(-/-) type II cells were viable and, like their wild-type counterparts, exhibited normal differentiation characteristics.",
      "citation": {
        "db": "PubMed",
        "db_id": "17413030"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 3,
      "key": "3e2f30c2c42ce69230dad7f5b285c94a"
    },
    {
      "relation": "hasComponent",
      "source": 118,
      "target": 13,
      "key": "18daf0568be38eabc155940e935136eb"
    },
    {
      "relation": "hasComponent",
      "source": 119,
      "target": 13,
      "key": "931cba4379cc41ee585acf65e96e0de0"
    },
    {
      "relation": "hasVariant",
      "source": 120,
      "target": 121,
      "key": "9189bbd696e08ae7137bdc34b83014b8"
    },
    {
      "relation": "hasVariant",
      "source": 120,
      "target": 122,
      "key": "a168833b9b225c376b1d124a625abee5"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "neutrophil stimulation with pro-inflammatory signals results in degradation of IkappaBalpha that occurs in both cytoplasm and nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12244195"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "c84a6dccfb8e31e2990653e9eaa43a99"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "MIP-1alpha treatment stimulated the degradation of IkappaBalpha, a cytoplasmic inhibitor of NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "11152622"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "2f493ddda3168e2e2fcf96f13606dc03"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Ubiquitin-tagged Ikappa Balpha  is degraded by the proteasome releasing NF-kappa B for migration to the nucleus. As a first approach to check the role of NF-kappa B in PKR-induced apoptosis, the NF-kappa B induction pathway was blocked by using the specific proteasome inhibitors, lactacystin and PSI.",
      "citation": {
        "db": "PubMed",
        "db_id": "10373514"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "ad394371a2e0423aeea47a7618cb67d9"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "CHUK specifically phosphorylates IkappaB-alpha on both serine 32 and serine 36, modifications that are required for targeted degradation of IkappaB-alpha via the ubiquitin-proteasome pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "9244310"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "2bfa6fe0e04ffe4b7e19eca345d9e11c"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The Bcl-2-mediated loss of IkappaBalpha could be prevented by the proteasome inhibitor lactacystin, consistent with the notion that the targeted degradation of IkappaBalpha consequent to overexpression of Bcl-2 utilizes the ubiquitin-proteasome pathway.  This was further tested in human 293 cells in which the N-terminal region of IkappaBalpha was identified to be an important regulatory site for Bcl-2. Deletion of this region or a serine to alanine substitution mutant at amino acids 32 and 36, which are defective for both phosphorylation and degradation, were more resistant than wild type IkappaBalpha to the inhibitory effects of Bcl-2.",
      "citation": {
        "db": "PubMed",
        "db_id": "9727009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "dad9caeca3481bf334f48b5331e2c557"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "0f9b7083052f9bff68ac6df0c057d3ba"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "ursodeoxycholic acid UDCA inhibited TGF-beta1-induced degradation of nuclear factor kappaB (NF-kappaB) and its inhibitor IkappaB (p < 0.05).",
      "citation": {
        "db": "PubMed",
        "db_id": "14514686"
      },
      "annotations": {
        "cl": {
          "0000182": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "3c16c12b2fa1d44e36a4954e667f0a5d"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "agents that inhibit NF?B activation are desired, and are currently being pursued,based on strategies that seek to maintain levels of endogenous NF?B-inhibiting I?B-family proteins, by either suppressing the IkB kinases (IKKs) responsible for phosphorylation of IkBalpha (which induces its polyubiquitination) or blocking the proteolytic activity of the 26s proteasome responsible for degrading IkB following ubiquitination (Figure 2A).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "89d42d98cf5635dca8d133571237efa9"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "CD86 stimulation also increased the level of IkappaB-alpha phosphorylation but in a protein kinase C-independent manner",
      "citation": {
        "db": "PubMed",
        "db_id": "15024018"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "3937733bcee177ff24e9b4ad9f0b2556"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
      "citation": {
        "db": "PubMed",
        "db_id": "10699758"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "464e560dbce77e9737d96ee301f3e895"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "# from full text # Here we show that UVC radiation leads to activation of a signaling pathway, distinct from the IKK pathway, which induces I?B? degradation in a manner dependent on phosphorylation of a cluster of C-terminal sites. The kinase that phosphorylates these sites is CK2.",
      "citation": {
        "db": "PubMed",
        "db_id": "14580335"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "9e03dc6c1ca3c8881577278c19e92f55"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Moreover, immunopurified beta-TrCP ubiquitinates phosphorylated IkappaBalpha at specific lysines in the presence of Ub-activating (E1) and -conjugating (Ubch5) enzymes.",
      "citation": {
        "db": "PubMed",
        "db_id": "9990853"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "729e889cebdd435e86fc7fdb2b791259"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "5alpha-dihydrotestosterone achieved this effect through maintenance of IkappaBalpha protein levels in the face of phorbol ester, a stimulus that results in IkappaBalpha degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "8824277"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "5114151e19ba631a5a4c19129660a9a9"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Activation of NF-kappaB mainly occurs via IkappaB kinase (IKK)-mediated phosphorylation of inhibitory molecules, including IkappaBalpha",
      "citation": {
        "db": "PubMed",
        "db_id": "15653325"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "7d0293e988b5b57ce816f431a3ef54fb"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "We demonstrated recently that BCL11B controls expression from the IL (interleukin)-2 promoter through direct binding to the US1 (upstream site 1). In the present study, we provide evidence that BCL11B also participates in the activation of IL-2 gene expression by enhancing NF-kappaB (nuclear factor kappaB) activity in the context of TCR (T-cell receptor)/CD28-triggered T-cell activation. The enhanced IkappaB degradation in cells with increased levels of BCL11B was specific for T-cells activated through the TCR, but not for cells activated through TNFalpha (tumour necrosis factor alpha) or UV light, and was caused by increased activity of IkappaB kinase, as indicated by its increase in phosphorylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18831712"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "ea330d5286540b79fd0849e8ad3b5708"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Consistent with this, these reagents also eliminate the ability of the Skp1-CUL1-HOS-ROC1 E3 ligase complex to support the ubiquitination of IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "10748083"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "f291d796d7606e8ee8753f528c636d0b"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
      "citation": {
        "db": "PubMed",
        "db_id": "18955562"
      },
      "annotations": {
        "cl": {
          "0000767": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "e47548cb63266aa67f60cfa6b174548b"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "fro full text Results - Plumbagin inhibited TPA-induced DNA-binding activities of NF-kB, c-Fos, and c-Jun/IkBa degradation and phosphorylation in A549 cells",
      "citation": {
        "db": "PubMed",
        "db_id": "19768635"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "7c4efca165e71a8162f2e2f10f5f50db"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The mechanism of adiponectin action in endothelial cells has been further investigated. TNF-A activates nuclear transcription factor NF-KB in these cells by stimulating protein kinase NIK (NF-kB inducing kinase), which phosphorylates the NF-kB inhibitor, IkB, initiating its degradation and thus leading to NF-KB activation. NF-KB stimulates the expression of cytokines and adhesion molecules involved in the inflammatory process.",
      "citation": {
        "db": "PubMed",
        "db_id": "15916985"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "ec91a1d0db2ac28fc180d16efb6053d6"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "5d50763857cfd7547e6e2ee35cf697e5"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "phosphorylation and ubiquitination-dependent degradation of IkappaBalpha, the cytoplasmic inhibitor of NFkappaB, via the inducible IkappaB kinase (IKK) complex, liberates NFkappaB to translocate into the nucleus and to transcriptionally activate its target genes, including the IL2 gene",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "5aed1e9148d974dd2b64d1d9fccf7d83"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "CSM-induced activation of TLR-4 has been shown to induce IRAK1 phosphorylation and TRAF6 degradation. An increase in IkB phosphorylation and degradation is also observed which ultimately leads to the translocation of NF-kB (p65) into the nucleus. The ability of cigarette smoke condensate (CSC) to activate NF-kB has also been demonstrated in another study using U937 cells. CSC has been shown to induce the activation of IKK (-a and -b) at 15 minutes post treatment, which resulted in increased phosphorylation of I?-B? at serine 32, resulting in Ik-Ba degradation and subsequent activation of NF-kB [53].",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "05c968029fa2e99ec7b5b86af6543c5b"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Furthermore, TWEAK induced rapid phosphorylation of IkappaB-alpha in human keratinocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15140220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "d7589dd8eddb4c0b4e27b5625ba5e51e"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "We found that IL-1 caused rapid phosphorylation of ERK1/2, JNK, p38, MKK3/6, Akt, IKK, c-Jun, ATF-2, ATF-1, CREB, p65, and IKBa, induced the degradation of IKBa and IKBe, and activated the synthesis of c-fos (Fig. 4)",
      "citation": {
        "db": "PubMed",
        "db_id": "19074142"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "eeb7bf54d37cd0bfd1be65ac9436b608"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The microtubule disassembly also induced IkappaB degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11306700"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "580e0b72d939b50f789fd0ee95d98a3b"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The actual recognition of N-terminally phosphorylated IKappaBs is carried out by aWD repeat- and F box-containing protein called beta-TrCP (Ben-Neriah, 2002). Upon ubiquiti-nation, the IKappaB proteins are rapidly degraded by the proteasome,",
      "citation": {
        "db": "PubMed",
        "db_id": "11983155"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "6fa347af3b2146f95fac42942e2f4716"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "It also associates specifically with phosphorylated IkappaBalpha and beta-catenin destruction motifs, probably functioning in multiple transcriptional programs by activating the NF-kappaB pathway and inhibiting the beta-catenin pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "11850407"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "d8d6c3c66ce6699a3a629325d6cca7de"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "We investigated its role in NF-?B activation and ROS production induced by TNF-? by using rapamycin (sirolimus), a well-characterized immunosuppressant and potent inhibitor of the signaling cascade. As described above, the phosphorylation and subsequent degradation of I?B play a critical role in regulating NF-?B translocation to the nucleus and subsequent transcriptional regulation. In Figure 6, we asked if rapamycin has any effect on TNF-?-induced degradation of I?B?; clearly, it did. I?B? is largely stabilized by the pretreatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "18463678"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "fa2702e8d5ecbdb83de7c02bf8f2347f"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "ctivation of NF-kappaB by TNF and IL-1 is initiated by the phosphorylation of the inhibitory subunit, IkappaB, which targets IkappaB for degradation and leads to the release of active NF-kappaB.",
      "citation": {
        "db": "PubMed",
        "db_id": "9418855"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "ef9a55a4bb5f1798f37d8236fb743eed"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "To exclude off-target effects, SphK1 expression was also downregulated with siRNAs targeted to two other regions of the SphK1 sequence and both inhibited TNF-alpha-induced phosphorylation of IkBalpha and IKKalpha/beta (Supplementary Fig. 2a). Similar results were obtained in several other cell types (Supplementary Fig. 2b), suggesting that SphK1 has a general role in the canonical NF-kappaB pathway.  To conclusively demonstrate the involvement of SphK1, we also used pharmacological and genetic approaches. The specific SphK1 inhibitor, SK1-I, which decreases intracellular S1P levels 6, reduced TNF-alpha-induced I?B? degradation and phosphorylation of IKKalpha/beta (Fig. 1b)",
      "citation": {
        "db": "PubMed",
        "db_id": "20577214"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "34c4aeec7720464450b4fc714f68c8b9"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Cytoplasmic and total cell protein extracts were analyzed by Western blotting for total IkBa and IkBa phosphorylated at serine residues 32 and 36. LPS exposure induced the rapid (within 15 min) phosphorylation and degradation of IkBa in both THP-1 cells (p,0.0001 for both processes; Figure 8, A and B) and elutriated primary human monocytes (p =0.003 and p,0.0001, respectively, ANOVA post hoc contrast of LPS vs. control for each; Figure 8, C and D).",
      "citation": {
        "db": "PubMed",
        "db_id": "19956541"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "0ceedafc6998a093db7bb595e5a2a848"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "62d7a11d8e8f64cc30c48f9058975e62"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Reconstitution of NEMO-deficient Jurkat cells with wild-type, but not NEMOL329P, restored TNF-alpha-induced IkappaB degradation. Similar results were obtained for TNF-alpha-induced IkappaB degradation (Fig. 3c, d) and NF-kappaB binding (Fig. 3e) in NEMO-deficient mouse embryonic fibroblast (MEF) subclones reconstituted with wildtype NEMO or NEMOL329P.",
      "citation": {
        "db": "PubMed",
        "db_id": "16547522"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "e55831160379775caf2c67b68f16ce6c"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "907bb66e74167408e7df8eefc0d6fc6e"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "OPN also induces NFkappaB activation through phosphorylation and degradation of IkappaBalpha by inducing the IKK activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12771144"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "6d14b1ef479bb8de86ad801eac72cef9"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "PAR-4 was found to directly inhibit the phosphorylation and degradation of I kappa B alpha, which led to the loss of NF kappa B activity causing repression of endogenous and radiation-induced Bcl-2 protein.",
      "citation": {
        "db": "PubMed",
        "db_id": "12170775"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "bda45af89c3c14a451186c1d7d66fd85"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The degradation of IKappaB-alpha at 20 min after stimulation by LPS was completely abolished in the presence of paxilline",
      "citation": {
        "db": "PubMed",
        "db_id": "16951373"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "409f1a86f7fffd97b4888fbd5d374d42"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "In turn, IKK2 phosphorylates inhibitor of NF-kappaB (I-kappaBalpha), leading to its ubiquitination and subsequent degradation by the proteasome. This frees up the p65 and p50 subunits of NF-kappaB, which translocate to the nucleus. Intranuclear NF-kappaB then binds to kappaB recognition sites in the 5'-promoter (upstream) region of inflammatory genes, resulting in increased gene transcription, messenger RNA, and synthesis of inflammatory proteins.",
      "citation": {
        "db": "PubMed",
        "db_id": "16865089"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "97a8a454d125e095d4e339b2884b9695"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "from the paper:",
      "citation": {
        "db": "PubMed",
        "db_id": "11909978"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "1537c1167812c8cbaa203ea8ce9ca8ec"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "In contrast to the serine 32/34 phosphorylation that triggers ubiquitination and degradation of IkappaBalpha, c-Abl-mediated phosphorylation at tyrosine 305 is associated with an increase of the IkappaBalpha protein stability. We also demonstrate that c-Abl targets the nuclear subpopulation of IkappaBalpha for phosphorylation and induces it to accumulate in the nucleus",
      "citation": {
        "db": "PubMed",
        "db_id": "12167702"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "c8b6239740df0ffd62ed9865631b22f7"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "SAA induced IkappaB-alpha degradation, RelA serine 536 (S536) phosphorylation, NF-kappaB transcriptional activity",
      "citation": {
        "db": "PubMed",
        "db_id": "15724247"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "d33831fcc964d7dd3ac9a77e33f69b5a"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Similar to wild-type A549 cells, treatment with TNF-? for 30 min induced I?B? degradation in vector control cells (Fig. 4B). On the other hand, TNF-?-induced I?B? degradation was blunted in DN I?B mutant cells (Fig. 4B), further supporting that these DN I?B mutant cells are less efficient in response to a NF-?B activator compared to the vector control cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15477018"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "153d0fd38fe84ac01d70ae180785d250"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The activation of TLR2 by Pam3CSK4 induced the degradation of the NF-kB inhibitor IkBa in human monocyte-derived macrophages. NF-kB activation was blocked by S1P at low micromolar concentrations. Statistically significant inhibition of TLR2-dependent NF-kB activation was observed with 1 mM S1P, which argues in favour of a receptor-dependent and physiologically relevant effect (Figure 4A).",
      "citation": {
        "db": "PubMed",
        "db_id": "18411230"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "565af14d5825d39a7e2814d2751a3198"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Moreover, IGF-I-mediated dephosphorylation of IkappaBalpha protects this molecule from tumor necrosis factor alpha (TNFalpha)-stimulated degradation; therefore, IGF-I also inhibits the nuclear translocation of NFkappaB (p65) induced by TNFalpha exposure.",
      "citation": {
        "db": "PubMed",
        "db_id": "10973957"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "cf926160af77450c211b39faaa4e479f"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Treatment of A549 cells with TGF-beta1-induced IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation, IkappaBalpha phosphorylation, IkappaBalpha degradation, p65 Ser536 phosphorylation, and kappaB-luciferase activity. The TGF-beta1-mediated increases in IKKalpha/beta phosphorylation, p65 Ser536 phosphorylation, and kappaB-luciferase activity were inhibited by LY 294002, an Akt inhibitor",
      "citation": {
        "db": "PubMed",
        "db_id": "17307160"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "907e476b7307d4c9d2de7969f1af3821"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "As shown in Fig. 10C, TNF-a rapidly induced complete degradation of I-kB-a",
      "citation": {
        "db": "PubMed",
        "db_id": "10946303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "23abe19a09f9c83e30a9ae8222cbcb82"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Figures 2C and D show that exposure to hyperoxia induced a degradation of I?B?, supporting the EMSA data for hyperoxia-induced NF-?B activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15477018"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "90b9055203d59283886b458bc4de075a"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "reducing endogenous levels of ASC using siRNA enhanced TNF- and LPS-induced degradation of the IKK substrate, IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "12486103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "f75eb58a1bb49ae1fabfe21db8b9a591"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Pretreatment with EGF protected monolayers by increasing native PKC-beta1 activity, decreasing IkappaBalpha phosphorylation/degradation, suppressing NF-kappaB activation (p50/p65 subunit nuclear translocation/activity), enhancing stable actin (increased F-actin-to-G-actin ratio), increasing stability of actin cytoskeleton, and reducing barrier hyperpermeability.",
      "citation": {
        "db": "PubMed",
        "db_id": "14602581"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "ec3a55db40143031d37f4dc6679cc786"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "PKC (protein kinase C) enzymes which phosphorylate IkappaBalpha, leading to its degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "15330761"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "39aa7b4aefbe31618a903e845c00611b"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
      "citation": {
        "db": "PubMed",
        "db_id": "20200353"
      },
      "annotations": {
        "cl": {
          "0000097": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "806ec8322be7e64b2a79f38ced7fe35c"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The incubation of ECs for 1 h in the presence of TNF-a alone induced significant degradation of IkB-a.",
      "citation": {
        "db": "PubMed",
        "db_id": "20351055"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "7000d803db07785940c27322f9822453"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "SUMO-1 modification was found to antagonize IkappaBalpha ubiquitination and protect it from degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "10788439"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "09be8ad86dbcb12d26f883128e64a888"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The lipopolysaccharide-induced degradation of IL-1R-associated kinase 1, IkappaBalpha, and IkappaBbeta was inhibited by elafin",
      "citation": {
        "db": "PubMed",
        "db_id": "16980310"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "7cabc541d572595b95b7995706f9849e"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "TNF-alpha induced both phosphorylation and degradation of IKappaB-alpha in A549 cells within several minutes",
      "citation": {
        "db": "PubMed",
        "db_id": "15489375"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "d928db79b006f8e59791bab63bb2134a"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "In human embryonic kidney 293 cells, IL-1beta induces IkappaB kinase beta (IKKbeta) activation, IkappaBalpha degradation, NF-kappaB transactivation, and weak Akt activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11976320"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "89ddf14e07adb7e1e019db18f01c7d24"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "366525fc7e0ecd67fa479bd4f50f96b1"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Immunoblotting analyses revealed that constitutively active AKT2 significantly promoted IkBalpha degradation (Fig. 4D).",
      "citation": {
        "db": "PubMed",
        "db_id": "12048203"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "ef6413934b4cd838c4394a919c3cfb81"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Stimulation of the MDMs with CSM for 30 min induced the phosphorylation of IRAK which was abolished by adding NAC (Fig. 6A). Moreover, CSM and LPS (as a control) degradated I?B-? and preincubation of MDMs with NAC suppressed the degradation of I?B-? induced by CSM (Fig. 6D).",
      "citation": {
        "db": "PubMed",
        "db_id": "19409098"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "1050c9fb745cb5ad1041a227525b815b"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "the I-kappaB kinase (IKK) is present and may phosphorylate I-kappaB during platelet activation. Coupled with intracellular calcium flux, this leads to I-kappaB dissociation from the NF-kappaB/I-kappaB complex and proteolysis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12297126"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "d5d9231c526742ab516672216e9a5163"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "TNF induced NF-kappaB activation as measured by DNA binding but deletion of PKR abolished this activation.This inhibition was associated with suppression of inhibitory subunit of NF-kappaB (IkappaB)alpha kinase (IKK) activation, IkappaBalpha phosphorylation and degradation, p65 phosphorylation and nuclear translocation, and NF-kappaB-dependent reporter gene transcription.",
      "citation": {
        "db": "PubMed",
        "db_id": "16924232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "3b2ebd3f89c3b6df59c02b7d808784f9"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "BetaTrCP and HOS are closely related F-box proteins, which play key roles in ubiquitination and degradation of beta-catenin and IkappaB through associating with those phosphorylated substrates and recruiting SCF E3 ubiquitin ligase",
      "citation": {
        "db": "PubMed",
        "db_id": "11850814"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "db7a127b37fc89e8046731bff8e7ad5c"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "In human neutrophils, TNF-alpha (200 U/ml) induced rapid I kappa B-alpha degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "15162444"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "da53d8f0dcdd710423380d7081480654"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Inducers of NF-kB, which include inflammatory cytokines, reactive oxygen species, and viral products, activate a dimeric IkB kinase (IKK) complex, which phophorylates IkBa leading to subsequent ubiquitination and degradation of IkBa and release of NF-kB proteins [33,34].",
      "citation": {
        "db": "PubMed",
        "db_id": "14561188"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "1ed6196a3e2b2b3804bf24fe09547349"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Expression of SphKG82D dramatically blocked the degradation of IKBa (Fig. 5a) and inhibited the NF-KB DNA binding activity in a dose-dependent manner (Fig. 5, b and c).",
      "citation": {
        "db": "PubMed",
        "db_id": "11777919"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "614cea52eda7f244875cd1750dea1720"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "overexpressing PKC-zeta results in lower steady-state protein levels of free IkappaBalpha, which is dependent on S293.",
      "citation": {
        "db": "PubMed",
        "db_id": "10764587"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "04b4e4e4eaba319c185d8768776f76b4"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "HSP27 does not affect I-kappaBalpha phosphorylation but enhances the degradation of phosphorylated I-kappaBalpha by the proteasome. The interaction of HSP27 with the 26S proteasome is required to activate the proteasome and the degradation of phosphorylated I-kappaBalpha. A protein complex that includes HSP27, phosphorylated I-kappaBalpha, and the 26S proteasome is formed",
      "citation": {
        "db": "PubMed",
        "db_id": "12897149"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "7a0b18a5f0293985a363e35e9b56ea0a"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Two related kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta, phosphorylate the IkappaB proteins, leading to their degradation and the subsequent activation of gene expression by NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "10779355"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "a2e29620c86e1b828ce70b09f5b72c18"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Here we show that beta-arrestin2 directly interacts with IkappaBalpha (inhibitor of NF-kappaB, the key molecule in innate and adaptive immunity) and thus prevents the phosphorylation and degradation of IkappaBalpha. Consequently, beta-arrestin2 effectively modulates activation of NF-kappa",
      "citation": {
        "db": "PubMed",
        "db_id": "15125834"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "83876963bf8549b98d32455a465b9b3b"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "These studies provide new evidence that the protein kinase CKII physically associates with I kappa B alpha in vivo, induces multisite (serine/threonine) phosphorylation, and is required for the basal and HIV-induced degradation of I kappa B alpha in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "8622692"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "1da0b820e7d7992a8faa7759d3a546bd"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "NFKB PDTC Preclinical treatment (44) PS-341 Preclinical treatment (45,46)",
      "citation": {
        "db": "PubMed",
        "db_id": "14587863"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "1577054ca9411d6eb5fdf95a9be83512"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "Activation of NF-kappaB by TNF-alpha occurred within 15 min and coincided with rapid degradation of IkappaBalpha. Co-treatment with NO donors did not prevent IkappaBalpha phosphorylation or degradation. However, after 2 h of TNF-alpha stimulation, NO donors inhibited NF-kappaB activation and augmented IkappaBalpha resynthesis and nuclear translocation by 2.5- and 3-fold, respectively. This correlated with a 75% reduction in TNF-alpha-induced VCAM-1 expression. In a time-dependent manner, NO donors alone caused the nuclear translocation of IkappaBalpha",
      "citation": {
        "db": "PubMed",
        "db_id": "9388244"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "0897a888dfad0cd25c9def47af67706e"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "The IRAK4:IRAK1:TRAF6 complex then interacts at the membrane with another preformed complex consisting of TAK1, TAB1 and TAB2.  This interaction induces phosphorylation of TAB2 and TAK1.  TAK1 is subsuequently activated in the cytoplasm, leading to the activation of IKK.  Activation leads to phosphorylation and degradation of IKB and consequent release of NFKB. Activation of TAK1 also results in the activation of MAP kinases and JNK.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "3570078743c8c35a733799e5b8df1960"
    },
    {
      "line": 20,
      "relation": "decreases",
      "evidence": "Induction of RAW264.7-derived NO inhibited lipopolysaccharide-induced endothelial VCAM-1 expression, which was reversed by the NO synthase inhibitor Nomega-monomethyl-L-arginine. These findings indicate that NO inhibits NF-kappaB activation and VCAM-1 expression by increasing the expression and nuclear translocation of IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "9388244"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "ea94c1623d222ab8a9960103bb307a3a"
    },
    {
      "line": 20,
      "relation": "decreases",
      "evidence": "Low shear for 6 h resulted in a reduction of IkappaBalpha levels, an activation of NF-kappaB, and an increase in kappaB-dependent vascular cell adhesion molecule 1 (VCAM-1) mRNA expression and endothelial-monocyte adhesion",
      "citation": {
        "db": "PubMed",
        "db_id": "12620896"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "b17278e8579319945351553b4e274712"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "In most cell types, the NFkB p50-p65 dimer is bound to one of the closely related endogneous  inhibitory proteins, collectively referred to as IkB, and is held inactive in the cyotplasm. A variety of extracellular signaling, including LPS, cytokines, stress factors have been reported to activate NFkb through phosphorylation of IkB at serine-32 and serine-36, dissociation of IkB from the complex, and translocation of the p50-p65 dimer fromt he cytolplasm to the nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12882972"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "23274ec089bd1001ec630bdff2f5543a"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "TAK1 activates the IkB kinase (IKK) complex (composed of IKKa, IKKb, and NEMO/IKKa) that in turn phosphorylates the NF-bB inhibitor IkB to induce its K48 polyubiquitination and proteasomal degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "19632174"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "1cb41e24c83adbcff583c0d4a4e5962d"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "Here, we demonstrate that in astrocyte cultures IGF-I regulates NFkappaB, a transcription factor known to play a key role in the inflammatory reaction. IGF-I induces a site-specific dephosphorylation of IkappaBalpha (phospho-Ser(32)) in astrocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "10973957"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "d94792e70aadcdff2e1ab2f6a53cbc4e"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "Exercise resulted in up to 2-fold increases in IKKalpha/beta phosphorylation in the soleus and red gastrocnemius muscles throughout the time course studied. In red gastrocnemius muscles, NF-kappaB activity increased 50% 1-3 h following 60 min of treadmill exercise, and returned to basal by 5 h. Contraction of isolated extensor digitorum longus (EDL) muscles in vitro increased IKKalpha/beta phosphorylation 10-fold and this was accompanied by a parallel increase in IkappaBalpha phosphorylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15888549"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "13801ec58c326b2b56a69656ec66975d"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "This was accompanied by reduced lung caspase-3 activity and defective degradation of NF-kappaB inhibitor IkappaB-alpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "18372427"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "94d661c22a62a80a0a21126523cf3561"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "59dd2cb6b8a090a1dacfc505a74b1c03"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "from the paper:",
      "citation": {
        "db": "PubMed",
        "db_id": "11909978"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "0af7ec4898af89e5de9d52062dfed06c"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "The key event in the NF-?B activation is the IL-1-induced phosphorylation and degradation of the inhibitory cytoplasmic protein I?B, which leads to the release of NF-?B, its translocation to the nucleus and binding and transcriptional regulation of its target genes",
      "citation": {
        "db": "PubMed",
        "db_id": "21776333"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 120,
      "target": 13,
      "key": "03876cca4b9d8e376dff709689007904"
    },
    {
      "line": 4,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 120,
      "key": "a78467dc22917dad60c30dff65ec72f9"
    },
    {
      "line": 4,
      "relation": "directlyIncreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 120,
      "key": "35d80c6608517198448dc7184bb41292"
    },
    {
      "line": 4,
      "relation": "directlyIncreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 120,
      "key": "8afd53e7fb43740fd126845962615d3d"
    },
    {
      "line": 4,
      "relation": "directlyIncreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 120,
      "key": "ee2696e33170192df8f510b04a30f305"
    },
    {
      "line": 4,
      "relation": "directlyIncreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 120,
      "key": "776969075a661bc5df71407f7bbf0b4d"
    },
    {
      "line": 219,
      "relation": "directlyIncreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 120,
      "key": "75ade5588a1c06284cd0b3bbff0d2329"
    },
    {
      "line": 219,
      "relation": "directlyIncreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 120,
      "key": "0ed06f0216caa8cb697431c3981d8def"
    },
    {
      "line": 219,
      "relation": "directlyIncreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 120,
      "key": "8e79514205cb7153c0d9f7119957e2eb"
    },
    {
      "line": 219,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 120,
      "key": "07e4f4ed9265b4974da8091e9172d629"
    },
    {
      "line": 219,
      "relation": "directlyIncreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 120,
      "key": "56950447ae60a29655d8e45bd9d70ac3"
    },
    {
      "line": 66,
      "relation": "directlyDecreases",
      "evidence": "In most cell types, the NFkB p50-p65 dimer is bound to one of the closely related endogneous  inhibitory proteins, collectively referred to as IkB, and is held inactive in the cyotplasm. A variety of extracellular signaling, including LPS, cytokines, stress factors have been reported to activate NFkb through phosphorylation of IkB at serine-32 and serine-36, dissociation of IkB from the complex, and translocation of the p50-p65 dimer fromt he cytolplasm to the nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12882972"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 123,
      "target": 13,
      "key": "48abf20f574a193f4cc5b49a5b644cf1"
    },
    {
      "line": 87,
      "relation": "decreases",
      "evidence": "Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.",
      "citation": {
        "db": "PubMed",
        "db_id": "16313356"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 93,
      "key": "c6459b0d77e91a6ed79ec282daa85eef"
    },
    {
      "line": 88,
      "relation": "decreases",
      "evidence": "Agonists of the nuclear LTB(4) receptor peroxisome proliferator-activated receptor-alpha, 8(S)-hydroxyeicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid, inhibited release of both IL-12 p40 and IL-10.",
      "citation": {
        "db": "PubMed",
        "db_id": "16313356"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 91,
      "key": "28b9720efd11b8d5daf82d23649e45cd"
    },
    {
      "line": 10,
      "relation": "decreases",
      "evidence": "Interference with Rho or Pyk2 inhibited cofilin inactivation and the migratory speed of DCs, but did not affect chemotaxis.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 125,
      "target": 75,
      "key": "18efbbd09ed304bef194e7ac95e66469"
    },
    {
      "line": 235,
      "relation": "increases",
      "evidence": "RFX subunits RFX5 and RFXAP are crucial for constitutive and CIITA-induced MHC class I and beta2m transactivation.",
      "citation": {
        "db": "PubMed",
        "db_id": "9806639"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 129,
      "target": 113,
      "key": "3a2ab49aa47469363a3b39ffb8794e72"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "SOCS3(-/-) DCs expressed lower levels of class II MHC, CD40, CD86, and IL-12 than wild-type (WT)-DCs both in vitro and in vivo, and showed constitutive activation of STAT3.",
      "citation": {
        "db": "Other",
        "db_id": "17675476"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 40,
      "key": "cb46502b66f424ee0b604671f5a58555"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "Restoration of SOCS-3 in lung cancer cells where SOCS-3 was methylation-silenced resulted in the down-regulation of active STAT3, induction of apoptosis, and growth suppression.",
      "citation": {
        "db": "PubMed",
        "db_id": "14617776"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 40,
      "key": "4bf4978ccdf7c997c08575f4823a61cc"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "(from text) Here we show that phosphorylation of STAT3 is prolonged in mouse Socs3-deficient macrophages  after stimulation with interleukin-6 (IL-6) but not IL-10, indicating that SOCS3 specifically affects signaling mediated by IL-6 and gp130.",
      "citation": {
        "db": "PubMed",
        "db_id": "12754506"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 40,
      "key": "044bbbe09606c26620df7776e513bd75"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "By contrast, Socs3 was found to be a major regulator of IL-23-mediated Stat3 phosphorylation and Th17 generation, and Stat3 directly binds to the IL-17A and IL-17F promoters. We conclude that Socs3 is an essential negative regulator of IL-23 signaling, inhibition of which constrains the generation of Th17 differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16698929"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 40,
      "key": "75caacd976cd005bab08a869a1e637d7"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.",
      "citation": {
        "db": "PubMed",
        "db_id": "15240880"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 40,
      "key": "4ef3ec35429bcacaa85b5ae83269037b"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "We further show that activation of STAT3 was inhibited by SOCS3 overexpression as well as by anti-IL-6 treatment during IgG IC-induced lung injury, as determined by EMSA.",
      "citation": {
        "db": "PubMed",
        "db_id": "16785559"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 40,
      "key": "ce50e0b661c2b1429209b2892eba174f"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": "We demonstrated that SOCS3 deletion in the liver resulted in hyperactivation of STAT3 and promoted ConA- and chemical-induced liver fibrosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16474852"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 40,
      "key": "72460dc88a8b9222880b55b1111c88bb"
    },
    {
      "line": 243,
      "relation": "association",
      "evidence": "Osteopontin functionally activates dendritic cells and induces their differentiation\ntoward a Th1-polarizing phenotype",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 39,
      "target": 4,
      "key": "ea7fdefe122d6837dd04467d984d6d4c"
    },
    {
      "line": 141,
      "relation": "increases",
      "evidence": "Importantly, the expression of survivin correlates with STAT3 activation in breast tumors, and the inhibition of this signaling pathway induces apoptosis [47,48]. Finally, it has also been shown that AKT is a direct target gene of STAT3, which binds directly to its promoter to enhance its expression [49].",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 40,
      "target": 81,
      "key": "baafb940ac1a23b5220e99595ce02963"
    },
    {
      "line": 57,
      "relation": "directlyIncreases",
      "evidence": "Together these experiments demonstrate that expression of IKKepsilon or TBK1 is sufficient to induce phosphorylation, nuclear translocation, and DNA binding of IRF-3 and IRF-7.",
      "citation": {
        "db": "PubMed",
        "db_id": "12702806"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 41,
      "target": 102,
      "key": "fe93a3c73275dbb19aa0781db0aba7d4"
    },
    {
      "line": 57,
      "relation": "directlyIncreases",
      "evidence": "In the present study, we demonstrate that inhibition by the protease occurs upstream of the noncanonical IKK-related kinases IKKepsilon and TBK-1, which phosphorylate IRF-3, through partial inhibition of the TLR adapter protein TRIF/TICAM1-dependent pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "15767399"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 41,
      "target": 102,
      "key": "8f4805c8b1598d49213859fac018dda8"
    },
    {
      "line": 57,
      "relation": "directlyIncreases",
      "evidence": "IKK-related kinases TBK1 and IKKepsilon have been shown to phosphorylate and activate IRF-3 and IRF-7, leading to the production of type 1 interferons and the development of a cellular antiviral state.",
      "citation": {
        "db": "PubMed",
        "db_id": "15556946"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 41,
      "target": 102,
      "key": "467c1bb907c4c09fc18ed999e5f85ff4"
    },
    {
      "line": 163,
      "relation": "increases",
      "evidence": "Unexpectedly, TGF-beta treatment also induced increased IL-6 production by pDC.",
      "citation": {
        "db": "PubMed",
        "db_id": "21518970"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 42,
      "target": 99,
      "key": "a4a481e4dd6d38eb314bcb4c9fd1bf15"
    },
    {
      "line": 186,
      "relation": "directlyIncreases",
      "evidence": "Stimulation with LPS also activates IRF3, and because LPS can induce the expression of both IFN- and IFN-inducible genes in a MyD88-independent manner, this indicates that IRF3 activation does not require MyD88. In fact, IRF3 activation, as shown by dimer formation and nuclear translocation, can be observed in MyD88-deficient cells47.  The activation of IRF3 by signalling through TLR3 is more rapid and potent than that triggered by TLR4 signalling, and this correlates with increased production of IFN- (S.A. and K.T., unpublished observations). Whereas activating TLR3 with poly I:C results in the C-terminal phosphorylation of IRF3, as detected using a phosphospecific antibody, stimulation with LPS does not induce detectable C-terminal phosphorylation70. However, we think that TLR3- and TLR4-mediated IRF3 activation probably differ quantitatively, rather than qualitatively, because it is more plausible that the phosphospecific antibody is not sensitive enough to detect IRF3 phosphorylation following TLR4 activation.  Two IKK-related proteins - IKK- (also known as inducible IKK, IKKi) and TBK1 (TRAF-family-member-associated NF-kB activator (TANK)-binding kinase 1; also known as NF-kB-activating kinase, NAK) - have recently been identified as the kinases that phosphorylate IRF3 in response to viral infection and stimulation of TLR3 (Refs 71,72). Overexpression of IKK- or TBK1 activates the promoter of the IFN- gene and of IFN-inducible genes and induces the phosphorylation and nuclear localization of IRF3. In addition, siRNA targeting of IKK- and TBK1, but not of IKK-, was observed to considerably reduce the TRIF-dependent activation of a reporter gene containing an IRF DNA-binding motif and to decrease the viral induction of IFN-4 and IFN- reporter genes71, 72. Furthermore, analysis of TBK1-deficient embryonic fibroblasts confirmed the essential role of TBK1 in IRF3-dependent gene expression mediated by TLR3 and TLR4 signalling73.  NF-kB activation. MyD88-deficient mice still activate NF-kB in response to stimulation with LPS, although the kinetics are delayed compared with wild-type mice. However, the activation of NF-kB in response to LPS is completely abrogated in mice lacking both MyD88 and TRIF, demonstrating that TRIF is essential for NF-kB activation through the MyD88-independent pathway50. Transcriptional activation of the IFN- gene requires activation of both NF-kB and IRF3, and in contrast to inflammatory cytokine production - which requires both early- and late-phase NF-kB activation, mediated by MyD88 and TRIF, respectively - production of IFN- can be induced by TRIF-mediated late-phase NF-kB activation alone (Fig. 4).     Figure 4 |  TRIF-dependent induction of IFN-.  The amino-terminal region of TRIF (Toll/interleukin-1-receptor (TIR)-domain-containing adaptor protein inducing interferon (IFN)-) interacts with both TRAF6 (tumour-necrosis-factor-receptor-associated factor 6) and TBK1 (TRAF-family-member-associated nuclear factor-kB (NF-kB) activator (TANK)-binding kinase 1). TRIF-dependent activation of TBK1 leads to the phosphorylation of IRF3 (IFN-regulatory factor 3), and TRAF6 mediates NF-kB activation. RIP1 (receptor-interacting protein 1) mediates the NF-kB activation that is induced through the carboxy-terminal region of TRIF. Activation of both NF-kB and IRF3 contributes to the activation of the IFN- gene. IB, inhibitor of NF-kB; TLR, Toll-like receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "15229469"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 73,
      "target": 41,
      "key": "985468a2719d2b719fa2016bd587da0c"
    },
    {
      "line": 187,
      "relation": "increases",
      "evidence": "We have demonstrated previously by using small interfering RNA knockdown of IKK-epsilon or TBK1 that the induction of type I IFN and related genes by TRIF depends on these kinases",
      "citation": {
        "db": "PubMed",
        "db_id": "14679297"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 73,
      "target": 58,
      "key": "9ac2eedf36c6d0fb9b60ac3e4bee0d24"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": "Both interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) signal via the adapter molecule MyD88.",
      "citation": {
        "db": "PubMed",
        "db_id": "16413919"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 116,
      "key": "f86f3488a89f16eb5c79170164023d36"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": "Furthermore, pretreatment of DCs with MyD88 and IL-1 receptor-associated kinase (IRAK) 1/4 inhibitors, or TLR2 antibody diminished the S. pneumoniae induced IL-23 and abolished morphine's inhibitory effects, indicating that S. pneumoniae induced IL-23 production depends on activation of the TLR2-MyD88-IRAK1/4 signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "21245149"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 116,
      "key": "9f9fdb889e536d33a42a57a06121d293"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "11441107"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 116,
      "key": "68f50b3ba90c11fe8942be4e1ba7cd86"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": "Bacterial lipoproteins (BLPs), which are expressed by all bacteria, are potent activators of Toll-like receptor-2 (TLR2). Here we show that the adaptor molecule, myeloid differentiation factor 88 (MyD88), mediates both apoptosis and nuclear factor-kappaB (NF-kappaB) activation by BLP-stimulated TLR2.",
      "citation": {
        "db": "PubMed",
        "db_id": "10880445"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 116,
      "key": "4319353ec58210cdc7493a2eb4231254"
    },
    {
      "line": 14,
      "relation": "increases",
      "evidence": "At this time point only polyI:C and polyI:C+R848 stimulated cells showed enhanced IFN gene expression (Fig. 7). SB202190 and LY294002, the inhibitors of MAPK p38 and PI3K, respectively, completely blocked TLR ligand-induced IFN-B and IFN-L1 gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "21040977"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 44,
      "target": 24,
      "key": "8e2e9876d5022e202d5883568c80a5ae"
    },
    {
      "line": 15,
      "relation": "increases",
      "evidence": "Interestingly, signaling through TLR1 or TLR3 induced similar responses, despite their use of different adaptor proteins, MydD88 for TLR1 and Trif for TLR3.",
      "citation": {
        "db": "PubMed",
        "db_id": "18772134"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 44,
      "target": 73,
      "key": "4aeaa783a1768894be86a3ae58abf7a9"
    },
    {
      "line": 15,
      "relation": "increases",
      "evidence": "TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 44,
      "target": 73,
      "key": "bf395f8f8ee94d2ed612823f1ab1aa08"
    },
    {
      "line": 15,
      "relation": "increases",
      "evidence": "From full text: TLRs signal through two main pathways, defined by the adaptor molecules used at the start of each. The best characterized of these is the MyD88-dependent pathway, common to all TLRs except TLR3, which results in rapid activation of the transcription molecules nuclear factor ?B (NF-?B), activator protein 1 and Elk-1 and induction of proinflammatory mediators such as tumour necrosis factor-? (TNF-?), interleukin-6 (IL-6) and cyclooxygenase-2.13,14 Activation of the NF-?B p65 and activator protein 1 transcription factors is reduced in endotoxin-tolerant cells.15 TLR7, -8 and -9 can also induce type I interferon (IFN) production in a MyD88-dependent manner, involving the activation of the interferon regulatory factor 5 (IRF-5)16 and IRF-717 transcription factors. The second, less well-studied pathway is thought to be limited to TLR3 and TLR4. TLR signalling via the adaptor molecules Toll/IL-1-receptor-domain-containing adaptor inducing IFN-? (TRIF) and TRIF-related adaptor molecule (TRAM) activates IRF-3 and IRF-7 and, ultimately, IFN-inducible genes such as IFN-?-inducible protein 10 (IP-10) and RANTES, via type I IFN production and autocrine activation of the JAK/STAT pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "17034424"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 44,
      "target": 73,
      "key": "be30892e9bcfda1cbfa2588c7d709eb9"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "MyD88 also interacts with IRF5 and IRF1 and is required for the activation of these IRFs. IRF5 was identified as being crucial for the induction of proinflammatory cytokines and type I IFNs by all TLRs tested...other TLR4-mediated MyD88-dependent signals, such as IRF5 activation,",
      "citation": {
        "db": "PubMed",
        "db_id": "17457343"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 45,
      "target": 116,
      "key": "bbf6799c7bafd3b72eba1df15d4e326a"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "An impaired IRAK4 activation was observed with TLR4 mutant PMN, in which the HMGB1-induced IRAK4 activity was attenuated by 64% compared with that in TLR4 WT PMN (Fig. 5B).",
      "citation": {
        "db": "PubMed",
        "db_id": "17475888"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 45,
      "target": 116,
      "key": "063e4b9cfe4c94b0e52bb436944045c1"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4).",
      "citation": {
        "db": "PubMed",
        "db_id": "18772134"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 45,
      "target": 116,
      "key": "3b225d39d23723514f73f7e4c405d28b"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "TLR4, in addition, activates NF-kappaB and MAP kinases via the MyD88-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 45,
      "target": 116,
      "key": "3fae9b4eed315a3f99f2650d4e22a485"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "Aggregation through TLR4 and 2 involved the production of NO, increase in cellular cGMP, and activation of PKG.",
      "citation": {
        "db": "PubMed",
        "db_id": "19945154"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 45,
      "target": 116,
      "key": "df47b4b1ce69c1542423263c711ed53c"
    },
    {
      "line": 60,
      "relation": "increases",
      "evidence": "CpG directly activates Stat3 within minutes through TLR9...TLR9 receptor activation induces immediate and direct activation of Stat3 in dendritic cells. A, TLR ligand-specific Stat3 activation in primary splenic DCs",
      "citation": {
        "db": "PubMed",
        "db_id": "19258507"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 59,
      "target": 40,
      "key": "ec73022330b53b7f4c4a7bddf3fd020a"
    },
    {
      "line": 61,
      "relation": "increases",
      "evidence": "These results suggest that CpG ODN activates the TLR9-MyD88-ERK1/2 pathway causing expression of Egr-1 and its target genes such as TF and Nab2, thus inducing foam cell formation.",
      "citation": {
        "db": "PubMed",
        "db_id": "19737531"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 116,
      "key": "6d36dacbd0d439f3a26e3f7f80310c61"
    },
    {
      "line": 61,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "11526399"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 116,
      "key": "4111b1469b9ce9041276fd273b85c8c0"
    },
    {
      "line": 61,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "12902324"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 116,
      "key": "134692454f45b49cb663396929bc2c10"
    },
    {
      "line": 61,
      "relation": "increases",
      "evidence": "TLR9 primarily induces ISRE gene expression through IRF7...TLR9, which exclusively couples to the MyD88-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 116,
      "key": "69856bbb01f16c9c06a92b167fb86e2d"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "All living organisms are exposed constantly to microorganisms that are present in the environment and need to cope with invasion of these organisms into the body. The vertebrate immune response can be divided into innate and acquired immunity, with innate immunity being the first line of defence against pathogens. By contrast, acquired immune responses are slower processes, which are mediated by T and B cells, both of which express highly diverse antigen receptors that are generated through DNA rearrangement and are thereby able to respond to a wide range of potential antigens. This highly sophisticated system of antigen detection is found only in vertebrates and has been the subject of considerable research. Far less attention has been directed towards innate immunity, as it has been regarded as a relatively nonspecific system, with its main roles being to destroy pathogens and to present antigen to the cells involved in acquired immunity. However, recent studies have shown that the innate immune system has a greater degree of specificity than was previously thought and that it is highly developed in its ability to discriminate between self and foreign pathogens1. This discrimination relies, to a great extent, on a family of evolutionarily conserved receptors, known as the Toll-like receptors (TLRs), which have a crucial role in early host defence against invading pathogens1, 2. Furthermore, accumulating evidence indicates that activation of the innate immune system is a prerequisite for the induction of acquired immunity, particularly for the induction of a T helper 1 (TH1)-cell response3, 4. This marked shift in our thinking has changed our ideas about the pathogenesis and treatment of cancers, and infectious, immune and allergic diseases. In the past few years, our knowledge of TLR signalling and the responses these receptors control has greatly increased. In this review, we discuss the TLRs, focusing on their signalling pathways.  TLR/IL-1R superfamily: structure and function  The discovery of the TLR family began with the identification of Toll, a receptor that is expressed by insects and was found to be essential for establishing dorsoventral polarity during embryogenesis5. Subsequent studies revealed that Toll also has an essential role in the insect innate immune response against fungal infection6. Homologues of Toll were identified through database searches, and so far, 11 members of the TLR family have been identified in mammals. The TLRs are type I integral membrane glycoproteins, and on the basis of considerable homology in the cytoplasmic region, they are members of a larger superfamily that includes the interleukin-1 receptors (IL-1Rs). By contrast, the extracellular region of the TLRs and IL-1Rs differs markedly: the extracellular region of TLRs contains leucine-rich repeat (LRR) motifs, whereas the extracellular region of IL-1Rs contains three immunoglobulin-like domains (Fig. 1a).     Figure 1 |  TLR structure and signalling.  a | Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs) have a conserved cytoplasmic domain, that is known as the Toll/IL-1R (TIR) domain. The TIR domain is characterized by the presence of three highly homologous regions (known as boxes 1, 2 and 3). Despite the similarity of the cytoplasmic domains of these molecules, their extracellular regions differ markedly: TLRs have tandem repeats of leucine-rich regions (known as leucine rich repeats, LRR), whereas IL-1Rs have three immunoglobulin (Ig)-like domains. b | Stimulation of TLRs triggers the association of MyD88 (myeloid differentiation primary-response protein 88), which in turn recruits IRAK4 (IL-1R-associated kinase 4), thereby allowing the association of IRAK1. IRAK4 then induces the phosphorylation of IRAK1. TRAF6 (tumour-necrosis-factor-receptor-associated factor 6) is also recruited to the receptor complex, by associating with phosphorylated IRAK1. Phosphorylated ...",
      "citation": {
        "db": "PubMed",
        "db_id": "15229469"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 48,
      "target": 108,
      "key": "36d1511536279b93e2340ff9971d264b"
    },
    {
      "line": 223,
      "relation": "directlyIncreases",
      "evidence": "Here we show that the MAPKK kinase TAK1 acts upstream of NIK in the IL-1-activated signalling pathway and that TAK1 associates with TRAF6 during IL-1 signalling.",
      "citation": {
        "db": "PubMed",
        "db_id": "10094049"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 48,
      "target": 108,
      "key": "5525bff7a3664f19f8d64f7a67569f80"
    },
    {
      "line": 224,
      "relation": "directlyIncreases",
      "evidence": "Furthermore, the adaptor molecule TRAF6 also bound and activated IRF7.",
      "citation": {
        "db": "PubMed",
        "db_id": "15361868"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 103,
      "key": "8116a5a1eae9eefceeebf2def73b94ff"
    },
    {
      "line": 242,
      "relation": "increases",
      "evidence": "Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation.",
      "citation": {
        "db": "Other",
        "db_id": "19553159"
      },
      "annotations": {},
      "source": 53,
      "target": 4,
      "key": "b60a6e5be1d6df1b2b8e10e6655f344e"
    },
    {
      "line": 238,
      "relation": "increases",
      "evidence": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 24,
      "target": 20,
      "key": "c9ab7a42a5758fc2a797b5b565374149"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "These demonstrate that Ang II is capable of inducing CRP generation in macrophages via AT(1)-ROS-ERK1/2/p38MAPK-NF-kB signal pathway, which contributes to better understanding of the proinflammatory and proatherosclerotic actions of Ang II.",
      "citation": {
        "db": "PubMed",
        "db_id": "21325823"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "abb202b043b687a716578360d8000d51"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "p38 activity was required to enhance the accessibility of the cryptic NF-kappa B binding sites contained in H3 phosphorylated promoters, which indicated that p38-dependent H3 phosphorylation may mark promoters for increased NF-kappa B recruitment.",
      "citation": {
        "db": "PubMed",
        "db_id": "11743587"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "99d24db747718fec4fbed7e3788f9d5b"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "Thus, suppression of p38 activity using SB203580 and siRNA transfection resulted in the significant reduction of IKK activity, DC maturation, and CXCL2 upregulation by toxin A. These results suggest that p38 MAPK may lead to the activation of IKK and NF-kappaB signaling, resulting in enhanced DC maturation and CXCL2 expression in response to C. difficile toxin A stimulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18985311"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "fad7b8055ee6289fbac88cf087cb7fca"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "PMA stimulation resulted in translocation of NF?B and this translocation was inhibited by both SB-202190 and bis I (Fig. 6). (SB-202190 is a p38 inhibitor)",
      "citation": {
        "db": "PubMed",
        "db_id": "18675993"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "b7465bd08e79a5e6bfbcc293331b3a22"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "RAGE-mediated NF-kappaB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant.",
      "citation": {
        "db": "PubMed",
        "db_id": "11375353"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "0211e8faa2ac054c406bd05005f4d203"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17652082"
      },
      "annotations": {
        "cl": {
          "0000182": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "7d7c590501c0b64319154d3e7b595d1c"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "from full text - Depletion of ATM also decreased NF-kB reporter activity— to roughly the same level as p38MAPK inhibition (Figure 5E, Po0.001). Although increased concentrations of SB203580 had no additional effect on NF-kB reporter output (data not shown), the combined treatment of SB203580 and ATM depletion had a synergistic effect, lowering NF-kB transcriptional activity to PRE control levels (Figure 5E, SBþshATM).",
      "citation": {
        "db": "PubMed",
        "db_id": "21399611"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "c6d5ba42a1aed673367026d8d5737548"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "Treatment of the cells concurrently with SB203580, a specific p38MAPK inhibitor, robustly blocked activation of NFkappaB transcriptional activity",
      "citation": {
        "db": "PubMed",
        "db_id": "17196679"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "aadc2c0c4ae50182457f110b0857592c"
    },
    {
      "line": 239,
      "relation": "increases",
      "evidence": "IL-18 treatment markedly increased phospho-ATF-2 (Thr71) levels in HCMEC, and this effect was blocked by the IL-18BPa/Fc chimera (Fig. 5A). Furthermore, treatment with the p38PMAPK inhibitor SB203580 strongly inhibited IL-18-mediated ATF-2 phosphorylation (Fig. 5B). Inhibition of p38MAPK also attenuated p65 phosphorylation (Fig. 5C) and NF-?B-driven reporter gene activity (Fig. 5D). Together, these results demonstrate that IL-18 induced NF-?B activation via p38MAPK activation (Fig. 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "16325763"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 13,
      "key": "5e7dc11e4a41fa716f92abb8546f4d73"
    },
    {
      "line": 176,
      "relation": "increases",
      "evidence": "CCR7 also induced activation of the GTPase Rho, the tyrosine kinase Pyk2, and inactivation of cofilin. Pyk2 activation was independent of Gi  and Src and was dependent on Rho.",
      "citation": {
        "db": "PubMed",
        "db_id": "15778365"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 22,
      "target": 125,
      "key": "6e714f8374c29686f0c24a2ce3344cf7"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "Cancer arises from a stepwise accumulation of genetic changes that liberates neoplastic cells from the homeostatic mechanisms that govern normal cell proliferation. In humans, at least four to six mutations are required to reach this state, but fewer seem to be required in mice. By rationalizing the shared and unique elements of human and mouse models of cancer, we should be able to identify the molecular circuits that function differently in humans and mice, and use this knowledge to improve existing models of cancer.",
      "citation": {
        "db": "PubMed",
        "db_id": "12044009"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 23,
      "target": 42,
      "key": "acc60b1ab080ffb339a3744f7024307d"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "This process involves a TGF-beta/Smad signal, because TGF-beta treatment induced Smad2 phosphorylation in pDC and blockade of TGF-beta signaling with the SD208 TGF-betaRI kinase inhibitor abrogated Th17 commitment induced by TGF-beta-treated pDC.",
      "citation": {
        "db": "PubMed",
        "db_id": "21518970"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 23,
      "target": 42,
      "key": "22da02acb0af8944657b6fac3f99f03c"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation",
      "citation": {
        "db": "PubMed",
        "db_id": "16120811"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 23,
      "target": 42,
      "key": "65e73844ac6af6f07aefffc69fd4cdb2"
    }
  ]
}